Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
48000,,,1495592,[],CHEMBL834507,Efficacy against mice infected with Staphylococcus aureus ATCC 25923 upon s.c. administration,F,,,BAO_0003036,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,1,=,,ED50,mg.kg-1,,0.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,0.6
48001,,,1495593,[],CHEMBL832516,Efficacy against mice infected with MRSA-32 upon s.c. administration,F,,,BAO_0003036,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,1,=,,ED50,mg.kg-1,,29.97,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,29.97
48002,,,1495594,[],CHEMBL832517,Efficacy against mice infected with MRSA-33 upon s.c. administration,F,,,BAO_0003036,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,1,=,,ED50,mg.kg-1,,66.12,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,66.12
48003,,,1495595,[],CHEMBL836109,Mutant prevention concentration against methicillin resistant Staphylococcus aureus-32 done for 48 h at 37 degree C with compound,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,0,=,,MPC,ug ml-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC,ug ml-1,UO_0000274,,10.0
48004,,,1495596,[],CHEMBL836110,Mutant prevention concentration aganist methicillin resistant Staphylococcus aureus-33 done for 48 hr at 37 degree C with compound,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,0,=,,MPC,ug ml-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC,ug ml-1,UO_0000274,,10.0
48005,,,1495597,[],CHEMBL831471,Mutant prevention concentration aganist methicillin resistant Staphylococcus aureus-5023 done for 48 hr at 37 degree C with compound,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,0,=,,MPC,ug ml-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC,ug ml-1,UO_0000274,,10.0
48006,,,1495598,[],CHEMBL838134,Ratio of MPC to MIC aganist methicillin resistant Staphylococcus aureus-32,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,0,=,,MPC/MIC,,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC/MIC,,,,5.0
48007,,,1495599,[],CHEMBL838135,Ratio of MPC to MIC against methicillin resistant Staphylococcus aureus-33,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,0,=,,MPC/MIC,,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC/MIC,,,,5.0
48008,,,1495600,[],CHEMBL831777,Minimum inhibitory concentration against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
48009,,,1495601,[],CHEMBL838136,Ratio of MPC to MIC against methicillin resistant Staphylococcus aureus-5023,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,0,=,,MPC/MIC,,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC/MIC,,,,5.0
48010,,,1495602,[],CHEMBL835139,Frequency of resistance emergence for methicillin resistant Staphylococcus aureus-32,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,0,=,,FRE,,,4.51e-05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FRE,,,,4.51e-05
48011,,,1495603,[],CHEMBL835140,Frequency of resistance emergence for methicillin resistant Staphylococcus aureus-33,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,0,=,,FRE,,,2.1e-06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FRE,,,,2.1e-06
48012,,,1495604,[],CHEMBL835141,Frequency of resistance emergence for methicillin resistant Staphylococcus aureus-5023,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,0,=,,FRE,,,3.1e-05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FRE,,,,3.1e-05
48013,,,1495605,[],CHEMBL876455,Partition coefficient (logD2.0),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,1,=,,LogD,,,-1.33,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.33
48014,,,1495606,[],CHEMBL827011,Partition coefficient (logD7.4),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,386190,=,1,1,=,,LogD,,,-0.16,CHEMBL2362975,,No relevant target,,,,logD,,,,-0.16
48015,,,1495607,[],CHEMBL875746,Minimum inhibitory concentration against Staphylococcus haemolyticus ATCC 29970,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.06
48016,,,1495608,[],CHEMBL830690,Minimum inhibitory concentration against Staphylococcus saprophyticus ATCC 15305,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.25
48017,,,1495609,[],CHEMBL830804,Minimum inhibitory concentration against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
48018,,,1495610,[],CHEMBL831326,Minimum inhibitory concentration against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48019,,,1495611,[],CHEMBL830503,Minimum inhibitory concentration against Streptococcus pneumoniae ATCC 6303,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48020,,,1495612,[],CHEMBL831794,Minimum inhibitory concentration against Streptococcus pyogenes ATCC 19615,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
48021,,,1523947,[],CHEMBL829152,Inhibitory concentration against potassium channel HERG,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139598,Bioorg Med Chem Lett,2005.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://www.openphacts.org/units/Nanomolar,395900,=,1,1,=,,IC50,nM,,128824.96,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.89
48022,,,1689598,[],CHEMBL866051,Cytotoxicity against Hep2 cell line,F,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,438115,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,100.0
48023,,,1689637,[],CHEMBL865343,Inhibitory activity against Staphylococcus aureus ATCC 29213 wild type Topo 4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,"{'bei': '15.19', 'le': '0.29', 'lle': '3.73', 'sei': '7.28'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.1,1,http://www.openphacts.org/units/Nanomolar,438115,=,1,1,=,,IC50,nM,,800.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,uM,UO_0000065,,0.8
48024,,,1689676,[],CHEMBL865342,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
48025,,,1689715,[],CHEMBL865341,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.061,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.061
48026,,,1689754,[],CHEMBL865340,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.013
48027,,,1689958,[],CHEMBL867180,Antibacterial activity against Enterococcus faecium ATCC 49032,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.125
48028,,,1690049,[],CHEMBL867181,Antibacterial activity against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.125
48029,,,1690054,[],CHEMBL867182,Antibacterial activity against Streptococcus pyogenes ATCC 19615,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.061,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.061
48030,,,1690059,[],CHEMBL867183,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48031,,,1690064,[],CHEMBL867184,Antibacterial activity against Haemophilus influenzae type b ACH-0056,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.013
48032,,,1690069,[],CHEMBL867185,Antibacterial activity against Moraxella catarrhalis ATCC 8176,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.061,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.061
48033,,,1690074,[],CHEMBL867186,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13637,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,0.031
48034,,,1690079,[],CHEMBL867187,Antibacterial activity against Salmonella Typhimurium ATCC 14028,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.061,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.061
48035,,,1690084,[],CHEMBL867188,Antibacterial activity against Klebsiella pneumoniae ATCC 13883,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.031
48036,,,1690089,[],CHEMBL867189,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138996,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,438115,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
48037,,,1695217,[],CHEMBL865595,Antimicrobial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441547,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
48038,,,1695254,[],CHEMBL865596,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441547,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
48039,,,1695291,[],CHEMBL865597,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441547,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
48040,,,1695307,[],CHEMBL864433,Cytotoxicity against human Hep2 laryngeal carcinoma cell line,F,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,441547,>,1,1,>,,CC50,nM,,100000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,100.0
48041,,,1695505,[],CHEMBL863775,Inhibitory activity against wild type Escherichia coli gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,"{'bei': '16.25', 'le': '0.31', 'lle': '4.15', 'sei': '7.78'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.52,0,http://www.openphacts.org/units/Nanomolar,441547,=,1,1,=,,IC50,nM,,300.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.3
48042,,,1695521,[],CHEMBL864372,Inhibitory activity against wild type Staphylococcus aureus topoisomerase 4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,"{'bei': '15.19', 'le': '0.29', 'lle': '3.73', 'sei': '7.28'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.1,0,http://www.openphacts.org/units/Nanomolar,441547,=,1,1,=,,IC50,nM,,800.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,uM,UO_0000065,,0.8
48043,,,1804016,[],CHEMBL910493,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621376,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
48044,,,1804027,[],CHEMBL910494,Cytotoxicity against human Hep2 cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,621376,>,1,1,>,,CC50,nM,,100000.0,CHEMBL612558,,ADMET,,,,CC50,uM,UO_0000065,,100.0
48045,,,1804196,[],CHEMBL910518,Cytotoxicity against rat hepatocytes after 48 hrs,F,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,621376,>,1,1,>,,CC50,nM,,100000.0,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,,CC50,uM,UO_0000065,,100.0
48046,,,1804202,[],CHEMBL910510,Inhibition of Staphylococcus aureus topoisomerase 4 by decatenation assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.1,0,http://www.openphacts.org/units/Nanomolar,621376,=,1,1,=,,IC50,nM,,800.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.8
48047,,,1804208,[],CHEMBL910511,Inhibition of Staphylococcus aureus DNA gyrase by supercoiling assay,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,"{'bei': '11.34', 'le': '0.21', 'lle': '2.18', 'sei': '5.43'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.55,0,http://www.openphacts.org/units/Nanomolar,621376,=,1,1,=,,IC50,nM,,28000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,28.0
48048,,,1804214,[],CHEMBL910512,Inhibition of human topoisomerase 2 by DNA cleavage assay,B,,,BAO_0000179,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Micromolar,621376,>,1,0,>,,EC2,uM,,150.0,CHEMBL1806,Homo sapiens,DNA topoisomerase II alpha,9606.0,,,EC2,uM,UO_0000064,,150.0
48049,,,1804220,[],CHEMBL910513,Antibacterial activity against methicillin-sensitive Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621376,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
48050,,,1804226,[],CHEMBL910514,Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus 273/T/T/T,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621376,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
48051,,,1804232,[],CHEMBL910515,Cytotoxicity against human HepG2 cells after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,621376,>,1,1,>,,CC50,nM,,100000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,CC50,uM,UO_0000065,,100.0
48052,,,1819119,[],CHEMBL908583,Antibacterial activity against Streptococcus pyogenes M12 by time-kill curve assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142144,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625626,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg/L,UO_0000274,,0.125
48053,,,1828568,[],CHEMBL917977,Reduction of Mycobacterium tuberculosis H37Rv in orally dosed BALB/c mouse lung,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,=,1,0,=,,Log10 cfu,,,3.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,3.2
48054,,,1828952,[],CHEMBL908125,Cytotoxicity against primary human osteoblasts at 400 ug/ml assessed as LDH release after 24 hrs,A,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,625755,=,1,0,=,,Activity,%,,10.0,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,10.0
48055,,Active,1828964,[],CHEMBL909771,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA at 10 ug/ml after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,625755,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
48056,,,1828967,[],CHEMBL909772,Increase in lactate production in primary human osteoblasts at 25 to 50 ug/ml by ELISA,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,625755,=,1,0,=,,Activity,%,,10.0,CHEMBL612582,,Osteoblast,,,,Activity,%,UO_0000187,,10.0
48057,,,1829053,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,0,=,,IC20,ug ml-1,,80.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC20,ug ml-1,UO_0000274,,80.0
48058,,,1829054,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,1,=,,IC50,ug.mL-1,,160.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,ug ml-1,UO_0000274,,160.0
48059,,,1829055,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL612582,,Osteoblast,,,,IC50,ug ml-1,UO_0000274,,400.0
48060,,,1829056,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,0,=,,IC20,ug ml-1,,190.0,CHEMBL612582,,Osteoblast,,,,IC20,ug ml-1,UO_0000274,,190.0
48061,,,1829057,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,0,=,,IC20,ug ml-1,,110.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC20,ug ml-1,UO_0000274,,110.0
48062,,,1829058,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,1,=,,IC50,ug.mL-1,,230.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,ug ml-1,UO_0000274,,230.0
48063,,,1829059,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,1,=,,IC50,ug.mL-1,,170.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,ug ml-1,UO_0000274,,170.0
48064,,,1829060,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,0,=,,IC20,ug ml-1,,30.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC20,ug ml-1,UO_0000274,,30.0
48065,,,1829061,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,0,=,,IC20,ug ml-1,,90.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC20,ug ml-1,UO_0000274,,90.0
48066,,,1829062,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,1,=,,IC50,ug.mL-1,,320.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,ug ml-1,UO_0000274,,320.0
48067,,,1829063,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,1,=,,IC50,ug.mL-1,,110.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,ug ml-1,UO_0000274,,110.0
48068,,,1829064,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625755,=,1,0,=,,IC20,ug ml-1,,40.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC20,ug ml-1,UO_0000274,,40.0
48069,,,1829272,[],CHEMBL912048,Inhibitory activity against azide-resistant Escherichia coli J53,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
48070,,,1829278,[],CHEMBL912049,Inhibitory activity against Escherichia coli 12-1502,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
48071,,,1829284,[],CHEMBL912050,Inhibitory activity against Klebsiella pneumoniae 12-1183,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
48072,,,1829290,[],CHEMBL912051,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1183,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
48073,,,1829296,[],CHEMBL912052,Inhibitory activity against Klebsiella pneumoniae 35,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
48074,,,1829302,[],CHEMBL912053,Inhibitory activity against azide-resistant Escherichia coli J53 T35,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
48075,,,1829308,[],CHEMBL912054,Inhibitory activity against Klebsiella pneumoniae 07-006,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
48076,,,1829314,[],CHEMBL912055,Inhibitory activity against azide-resistant Escherichia coli J53 T07-006,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
48077,,,1829320,[],CHEMBL912056,Inhibitory activity against Klebsiella pneumoniae 03-222,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
48078,,,1829326,[],CHEMBL912057,Inhibitory activity against azide-resistant Escherichia coli J53 T03-222,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
48079,,,1829332,[],CHEMBL912058,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1502,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142151,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625672,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
48080,,,1833792,[],CHEMBL908132,Antimicrobial activity against Streptococcus pneumoniae R6,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48081,,,1833796,[],CHEMBL908133,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48082,,,1833800,[],CHEMBL908134,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48083,,,1833804,[],CHEMBL908135,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48084,,,1833808,[],CHEMBL908136,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48085,,,1833812,[],CHEMBL908137,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48086,,,1833816,[],CHEMBL908138,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48087,,,1833820,[],CHEMBL908139,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48088,,,1833824,[],CHEMBL908140,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48089,,,1833828,[],CHEMBL908141,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48090,,,1833832,[],CHEMBL908142,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48091,,,1833836,[],CHEMBL908143,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48092,,,1833840,[],CHEMBL908144,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79F and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48093,,,1833844,[],CHEMBL908145,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48094,,,1833848,[],CHEMBL908146,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48095,,,1833852,[],CHEMBL908147,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48096,,,1833856,[],CHEMBL908148,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48097,,,1833860,[],CHEMBL908149,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48098,,,1833864,[],CHEMBL908150,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625885,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48099,,,1834544,[],CHEMBL919451,Fraction unbound ligand in mouse plasma at 0.01 to 10 mg/litre,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,=,1,1,=,,Fu,,,0.077,CHEMBL613589,Mus musculus,Plasma,10090.0,,,Fu,,,,0.077
48100,,,1834933,[],CHEMBL906970,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81F and ParC D83N mutation after 19 passages by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48101,,,1834935,[],CHEMBL906972,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 35 passages by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48102,,,1834938,[],CHEMBL906975,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3665 with GyrA S81Y mutation after 38 passages by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48103,,,1834940,[],CHEMBL906977,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3676 with GyrA E85G, GyrB S478I and ParC S79Y mutation after 50 passages by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48104,,,1834942,[],CHEMBL906979,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3243 after 20 passages by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48105,,,1834945,[],CHEMBL906982,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81F mutation after 32 passages by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48106,,,1834947,[],CHEMBL906984,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 24 with GyrA S81Y, GyrB P413S and ParC S79F mutation after 50 passages by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48107,,,1834965,[],CHEMBL908694,Antibacterial activity against levofloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81Y and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48108,,,1834977,[],CHEMBL908695,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 3009 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48109,,,1834994,[],CHEMBL908696,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81F and ParC D83N mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48110,,,1835012,[],CHEMBL908697,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3009 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48111,,,1835043,[],CHEMBL908698,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48112,,,1835057,[],CHEMBL908699,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48113,,,1835070,[],CHEMBL908700,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 1077 with 23S rRNA A2058G mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48114,,,1835084,[],CHEMBL908701,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3665 with GyrA S81Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48115,,,1835094,[],CHEMBL908702,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3665 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
48116,,,1835113,[],CHEMBL908703,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3676 with GyrA E85G, GyrB S478I and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48117,,,1835135,[],CHEMBL908704,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3676 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48118,,,1835145,[],CHEMBL908705,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3243 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48119,,,1835155,[],CHEMBL908706,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 3243 with L22 insertion 93SFRPRA94 mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48120,,,1835165,[],CHEMBL908707,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3243 with 23S rRNA A2059T mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48121,,,1835175,[],CHEMBL908708,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81F mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48122,,,1835185,[],CHEMBL908709,Antibacterial activity against levofloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81Y and ParC D83Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48123,,,1835195,[],CHEMBL908127,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 24 with GyrA S81Y, GyrB P413S and ParC S79F mutation after 10 antibiotic-free subcultures by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48124,,,1835205,[],CHEMBL908128,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 2527 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48125,,,1835215,[],CHEMBL908129,"Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 37 with GyrA S81Y, GyrB E474K and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
48126,,,1835225,[],CHEMBL908130,Antibacterial activity against Streptococcus pneumoniae assessed as period of suppression of bacterial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,625876,=,1,0,=,,Post Antibiotic Effe,hr,,1.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Post Antibiotic Effe,hr,UO_0000032,,1.5
48127,,,1835586,[],CHEMBL917049,Antimicrobial activity against Mycobacterium tuberculosis H37Rv in 7H9 broth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626031,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,0.5
48128,,,1835587,[],CHEMBL917957,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in mouse J774A.1 macrophages,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,626031,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,mg/L,UO_0000274,,1.0
48129,,,1835617,[],CHEMBL917959,Antimicrobial activity against Mycobacterium tuberculosis H3Rv on day 7,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,=,1,0,=,,log10CFU/ml,,,3.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10CFU/ml,,,,3.0
48130,,Active,1835637,[],CHEMBL917960,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 1,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
48131,,Active,1835638,[],CHEMBL917961,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 7,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
48132,,Active,1835639,[],CHEMBL917962,Bactericidal activity in Mycobacterium tuberculosis H37Rv on day 14,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
48133,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1835653,[],CHEMBL917964,"Cmax in BALB/c mouse at 6 to 400 mg/kg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,626031,=,1,1,=,,Cmax,nM,,946.59,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,0.38
48134,,,1835654,[],CHEMBL917967,"AUC(0-infinity) in BALB/c mouse at 6 to 400 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,=,1,1,=,,AUC,ng.hr.mL-1,,25000.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug.hr/ml,,,25.0
48135,,,1835655,[],CHEMBL917970,"Half life in BALB/c mouse at 6 to 400 mg/kg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,626031,=,1,1,=,,T1/2,hr,,4.46,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,4.46
48136,,,1835665,[],CHEMBL917972,"Ratio of fraction AUC in Mycobacterium tuberculosis infected BALB/c mouse to MIC in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 19000 mg/kg, po",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,=,1,0,=,,RatioAUC/MIC,,,0.11,CHEMBL612558,,ADMET,,,,RatioAUC/MIC,,,,0.11
48137,,,1835667,[],CHEMBL917973,"Ratio of fraction Cmax in Mycobacterium tuberculosis infected BALB/c mouse to MIC in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 19000 mg/kg, po",A,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,=,1,0,=,,Ratio,,,1.0,CHEMBL612558,,ADMET,,,,Ratio,,,,1.0
48138,,,1835674,[],CHEMBL917974,"Drug level in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 19000 mg/kg, po",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,626031,=,1,0,=,,T>MIC,%,,0.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,T>MIC,%,UO_0000187,,0.0
48139,,,1835677,[],CHEMBL917975,"Toxicity in Mycobacterium tuberculosis infected BALB/c mouse model at 38 to 19000 mg/kg, po",T,,,BAO_0002117,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142211,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,626031,=,1,1,=,,LD50,mg.kg-1,,600.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,LD50,mg kg-1,UO_0000308,,600.0
48140,,,1836914,[],CHEMBL856454,Antibacterial activity against Streptococcus pneumoniae 3009 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48141,,,1836916,[],CHEMBL856455,Antibacterial activity against Streptococcus pneumoniae 1076 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48142,,,1836923,[],CHEMBL856457,Antibacterial activity against Streptococcus pneumoniae 3665 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48143,,,1836925,[],CHEMBL856459,Antibacterial activity against Streptococcus pneumoniae 3676 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48144,,,1836927,[],CHEMBL856458,Antibacterial activity against Streptococcus pneumoniae 3243 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48145,,,1836930,[],CHEMBL856460,Antibacterial activity against Streptococcus pneumoniae 19 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48146,,,1836932,[],CHEMBL856461,Antibacterial activity against Streptococcus pneumoniae 24 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625876,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48147,,,1847302,[],CHEMBL918716,Antibacterial activity against Staphylococcus aureus SA1199B overexpressing NorA at 5 ug by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142063,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Millimeter,631996,=,1,1,=,,IZ,mm,,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,31.0
48148,,,1847485,[],CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC50,ug ml-1,UO_0000274,,0.125
48149,,,1847491,[],CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48150,,,1847499,[],CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,MBC50,ug ml-1,,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MBC50,ug ml-1,UO_0000274,,0.125
48151,,,1847507,[],CHEMBL919647,Antimicrobial susceptibility of Staphylococcus lugdunensis isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,MBC90,ug ml-1,,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MBC90,ug ml-1,UO_0000274,,0.25
48152,,,1847521,[],CHEMBL919668,Increase in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,632006,=,1,0,=,,Activity,%,,27.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,27.0
48153,,,1847529,[],CHEMBL919669,Decrease in biofilm formation of Staphylococcus lugdunensis assessed as percent biofilm forming isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,632006,=,1,0,=,,Activity,%,,40.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,40.0
48154,,,1847542,[],CHEMBL919653,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL856 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.25
48155,,,1847550,[],CHEMBL919654,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2394 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,2.0
48156,,,1847558,[],CHEMBL919655,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2414 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.5
48157,,,1847566,[],CHEMBL919656,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2492 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.25
48158,,,1847574,[],CHEMBL919657,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2526 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.5
48159,,,1847582,[],CHEMBL919658,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2554 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,<=,1,0,<=,,BBC,ug ml-1,,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.125
48160,,,1847590,[],CHEMBL919659,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2588 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.5
48161,,,1847598,[],CHEMBL919660,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2622 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,2.0
48162,,,1847606,[],CHEMBL919661,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2639 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.25
48163,,,1847614,[],CHEMBL919662,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2640 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,2.0
48164,,,1847622,[],CHEMBL919663,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL2664 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,<=,1,0,<=,,BBC,ug ml-1,,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.125
48165,,,1847630,[],CHEMBL919664,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5204 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.5
48166,,,1847638,[],CHEMBL919665,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5254 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,0.5,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.5
48167,,,1847646,[],CHEMBL919666,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5256 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,=,1,0,=,,BBC,ug ml-1,,1.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,1.0
48168,,,1847654,[],CHEMBL919667,Antimicrobial susceptibility of Staphylococcus lugdunensis IDRL5258 biofilms after 24 hrs assessed as bacterial regrowth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632006,<=,1,0,<=,,BBC,ug ml-1,,0.125,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,BBC,ug ml-1,UO_0000274,,0.125
48169,,,1847662,[],CHEMBL919110,Effect on biofilm formation of Staphylococcus lugdunensis assessed as percent non-biofilm forming isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142066,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,632006,=,1,0,=,,Activity,%,,33.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,33.0
48170,,,1847823,[],CHEMBL920057,"Reduction of bacterial counts in Mycobacterium tuberculosis H37Rv infected Swiss mouse lung at 100 mg/kg, po for 5 days/week after 1 month",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142073,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,632057,=,1,0,=,,Log10 cfu,,,5.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,5.5
48171,,,1847824,[],CHEMBL920058,"Reduction of bacterial counts in Mycobacterium tuberculosis H37Rv infected Swiss mouse lung at 100 mg/kg, po for 5 days/week after 2 months",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142073,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,632057,=,1,0,=,,Log10 cfu,,,4.3,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,4.3
48172,,Active,1847833,[],CHEMBL920064,"Reduction of lung lesions in Mycobacterium tuberculosis H37Rv infected Swiss mouse at 100 mg/kg, po for 5 days/week after 2 months",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142073,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,632057,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
48173,,,1848140,[],CHEMBL916441,Antimicrobial activity against Nocardia cyriacigeorgica after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,,MIC,ug.mL-1,,6e-05,CHEMBL4296583,Nocardia cyriacigeorgica,Nocardia cyriacigeorgica,135487.0,,,MIC,ug/L,UO_0000274,,0.06
48174,,,1848148,[],CHEMBL916442,Antimicrobial activity against Nocardia farcinica after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,,MIC,ug.mL-1,,6e-05,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,,MIC,ug/L,UO_0000274,,0.06
48175,,,1848156,[],CHEMBL916443,Antimicrobial activity against Nocardia otitidiscaviarum after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,,MIC,ug.mL-1,,6e-05,CHEMBL613233,Nocardia otitidiscaviarum,Nocardia otitidiscaviarum,1823.0,,,MIC,ug/L,UO_0000274,,0.06
48176,,,1848163,[],CHEMBL916444,Antimicrobial activity against Nocardia abscessus after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,1.0
48177,,,1848172,[],CHEMBL916445,Antimicrobial activity against Nocardia beijingensis after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,,MIC,ug.mL-1,,6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.06
48178,,,1848180,[],CHEMBL916446,Antimicrobial activity against Nocardia nova after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL612977,Nocardia nova,Nocardia nova,37330.0,,,MIC,ug/L,UO_0000274,,2.0
48179,,,1848189,[],CHEMBL916447,Antimicrobial activity against Nocardia veterana after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,=,1,1,=,,MIC,ug.mL-1,,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.5
48180,,,1848197,[],CHEMBL916448,Antimicrobial activity against Nocardia transvalensis after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,=,1,1,=,,MIC,ug.mL-1,,0.00012,CHEMBL613234,Nocardia transvalensis,Nocardia transvalensis,37333.0,,,MIC,ug/L,UO_0000274,,0.12
48181,,,1848205,[],CHEMBL916449,Antimicrobial activity against Nocardia carnea after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,,MIC,ug.mL-1,,6e-05,CHEMBL4296582,Nocardia carnea,Nocardia carnea,37328.0,,,MIC,ug/L,UO_0000274,,0.06
48182,,,1848213,[],CHEMBL916450,Antimicrobial activity against Nocardia brasiliensis after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,,MIC,ug.mL-1,,6e-05,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,,MIC,ug/L,UO_0000274,,0.06
48183,,,1848220,[],CHEMBL916451,Antimicrobial activity against Nocardia sp. after 72 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142084,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632092,<=,1,1,<=,,MIC,ug.mL-1,,6e-05,CHEMBL612979,Nocardia sp.,Nocardia sp.,1821.0,,,MIC,ug/L,UO_0000274,,0.06
48184,,,1850154,[],CHEMBL920752,Antimicrobial susceptibility against Haemophilus influenzae A isolate with GyrA Glu83Cys and AcrR 97stop codon mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
48185,,,1850157,[],CHEMBL920753,"Antimicrobial susceptibility against Haemophilus influenzae A1 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
48186,,,1850160,[],CHEMBL920754,"Antimicrobial susceptibility against Haemophilus influenzae A2 with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
48187,,,1850163,[],CHEMBL920755,"Antimicrobial susceptibility against Haemophilus influenzae A3 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
48188,,,1850166,[],CHEMBL920756,"Antimicrobial susceptibility against Haemophilus influenzae A4 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
48189,,,1850169,[],CHEMBL920196,Antimicrobial susceptibility against Haemophilus influenzae B isolate with AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.06
48190,,,1850172,[],CHEMBL920197,Antimicrobial susceptibility against Haemophilus influenzae B1 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.25
48191,,,1850175,[],CHEMBL920198,Antimicrobial susceptibility against Haemophilus influenzae B2 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.25
48192,,,1850178,[],CHEMBL920199,Antimicrobial susceptibility against Haemophilus influenzae C isolate with AcrR Leu31His and Arg34Glu mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
48193,,,1850181,[],CHEMBL920200,"Antimicrobial susceptibility against Haemophilus influenzae C1 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.12
48194,,,1850184,[],CHEMBL920201,"Antimicrobial susceptibility against Haemophilus influenzae C2 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
48195,,,1850187,[],CHEMBL920202,"Antimicrobial susceptibility against Haemophilus influenzae C3 isolate with GyrA Asp88Asn, ParC Ser84Ile, AcrR Leu31His and Arg34Glu mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
48196,,,1850190,[],CHEMBL920203,"Antimicrobial susceptibility against Haemophilus influenzae D isolate with AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
48197,,,1850193,[],CHEMBL920204,"Antimicrobial susceptibility against Haemophilus influenzae D1 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
48198,,,1850196,[],CHEMBL920205,"Antimicrobial susceptibility against Haemophilus influenzae D2 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
48199,,,1850199,[],CHEMBL920206,"Antimicrobial susceptibility against Haemophilus influenzae D3 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
48200,,,1850202,[],CHEMBL920207,"Antimicrobial susceptibility against Haemophilus influenzae D4 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147114,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634942,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,2.0
48201,,,1866400,[],CHEMBL920153,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,634689,=,1,1,=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
48202,,,1866429,[],CHEMBL920154,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,634689,<=,1,1,<=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
48203,,,1866458,[],CHEMBL920155,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,634689,=,1,1,=,,MIC,nM,,15900.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,15.9
48204,,,1866487,[],CHEMBL920156,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,634689,<=,1,1,<=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
48205,,,1866841,[],CHEMBL915677,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 75 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634949,=,1,0,=,,fAUC/MIC,,,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,24.0
48206,,,1866871,[],CHEMBL915676,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 50 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634949,=,1,0,=,,fAUC/MIC,,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,16.0
48207,,,1866872,[],CHEMBL914192,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 50 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634949,=,1,0,=,,fAUC/MIC,,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,32.0
48208,,,1866873,[],CHEMBL914191,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 400 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634949,=,1,0,=,,fAUC/MIC,,,236.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,236.0
48209,,,1866874,[],CHEMBL914187,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 100 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634949,=,1,0,=,,fAUC/MIC,,,63.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,63.0
48210,,,1867238,[],CHEMBL914132,Susceptibility of penicillin-resistant Streptococcus pneumoniae 335 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
48211,,,1867243,[],CHEMBL914133,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48212,,,1867250,[],CHEMBL914134,Effect on 0.5 ug/ml sitofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48213,,,1867255,[],CHEMBL914135,Effect on 1 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48214,,,1867259,[],CHEMBL915624,Effect on 16 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48215,,,1867264,[],CHEMBL915625,Effect on 16 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 335 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48216,,,1867269,[],CHEMBL915626,Susceptibility of penicillin-resistant Streptococcus pneumoniae 334 by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
48217,,,1867273,[],CHEMBL914661,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48218,,,1867277,[],CHEMBL915629,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48219,,,1867281,[],CHEMBL915630,Effect on 1 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48220,,,1867285,[],CHEMBL915631,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48221,,,1867289,[],CHEMBL915632,Effect on 32 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 334 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48222,,,1867294,[],CHEMBL915633,Susceptibility of penicillin-resistant Streptococcus pneumoniae 216 by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
48223,,,1867298,[],CHEMBL915634,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48224,,,1867304,[],CHEMBL915635,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48225,,,1867308,[],CHEMBL915636,Effect on 2 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48226,,,1867312,[],CHEMBL915637,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48227,,,1867320,[],CHEMBL915638,Effect on 32 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48228,,,1867329,[],CHEMBL915639,Susceptibility of penicillin-resistant Streptococcus pneumoniae 217 by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48229,,,1867336,[],CHEMBL915640,Effect on 0.03 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48230,,,1867341,[],CHEMBL915641,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48231,,,1867345,[],CHEMBL915642,Effect on 0.5 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48232,,,1867353,[],CHEMBL915643,Effect on 4 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48233,,,1867357,[],CHEMBL915033,Effect on 8 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 216 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48234,,,1867363,[],CHEMBL915034,Susceptibility of penicillin-resistant Streptococcus pneumoniae 218 by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
48235,,,1867373,[],CHEMBL915035,Effect on 0.06 ug/ml DQ113-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48236,,,1867384,[],CHEMBL915036,Effect on 0.5 ug/ml sitafloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48237,,,1867389,[],CHEMBL914130,Effect on 2 ug/ml moxifloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48238,,,1867393,[],CHEMBL915037,Effect on 16 ug/ml levofloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48239,,,1867398,[],CHEMBL915038,Effect on 16 ug/ml ciprofloxacin-selected penicillin-resistant Streptococcus pneumoniae 218 mutant after five passages assessed as susceptibility by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48240,,,1867476,[],CHEMBL914131,Susceptibility of methicillin-sensitive/resistant Staphylococcus aureus single-step mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
48241,,,1867490,[],CHEMBL915039,Susceptibility of vancomycin-resistant Enterococcus species single-step mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,8.0
48242,,,1867511,[],CHEMBL915040,Susceptibility of drug-selected vancomycin-resistant Enterococcus species mutant by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1146198,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634751,=,1,1,=,,MIC,ug.mL-1,,64000.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,mg/ml,UO_0000274,,64.0
48243,,,1868292,[],CHEMBL919811,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
48244,,Not Determined,1868294,[],CHEMBL919277,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634867,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
48245,,,1868298,[],CHEMBL919807,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
48246,,Not Determined,1868303,[],CHEMBL919813,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634867,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
48247,,,1868304,[],CHEMBL919817,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA643 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
48248,,,1868320,[],CHEMBL919278,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA678 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
48249,,,1868342,[],CHEMBL919279,Antibacterial activity against Staphylococcus aureus Mu50 at pH 5,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634867,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
48250,,,1868469,[],CHEMBL919280,Effect on cellular viability of methicillin-sensitive Staphylococcus aureus ATCC 29213 by measuring the time required for recovery at 10 times MIC after 1 hr,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,634867,=,1,0,=,,Post anitbiotic effect,hr,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Post anitbiotic effect,hr,UO_0000032,,1.6
48251,,,1868470,[],CHEMBL919281,Effect on cellular viability of methicillin-resistant Staphylococcus aureus Mu50 at 10 times MIC by measuring the time required for recovery at 10 times MIC after 1 hr,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,634867,=,1,0,=,,Post anitbiotic effect,hr,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Post anitbiotic effect,hr,UO_0000032,,1.5
48252,,,1869730,[],CHEMBL914169,Peak free concentration at 800 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,,Activity,ug ml-1,,4.46,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,4.46
48253,,,1869731,[],CHEMBL914160,Peak free concentration at 50 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,,Activity,ug ml-1,,0.3,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.3
48254,,,1869732,[],CHEMBL914161,Peak free concentration at 75 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,,Activity,ug ml-1,,0.45,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.45
48255,,,1869733,[],CHEMBL914730,Peak free concentration at 100 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,,Activity,ug ml-1,,0.6,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.6
48256,,,1869734,[],CHEMBL914158,Peak free concentration at 200 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,,Activity,ug ml-1,,1.1,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,1.1
48257,,,1869735,[],CHEMBL914159,Peak free concentration at 400 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,0,=,,Activity,ug ml-1,,2.48,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,2.48
48258,,,1869812,[],CHEMBL914170,Half life at 100 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,,T1/2,hr,,12.02,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,12.02
48259,,,1869813,[],CHEMBL914172,Half life at 200 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,,T1/2,hr,,11.9,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,11.9
48260,,,1869819,[],CHEMBL914173,Half life at 400 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,,T1/2,hr,,11.66,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,11.66
48261,,,1869857,[],CHEMBL914174,Half life at 50 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,,T1/2,hr,,12.33,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,12.33
48262,,,1869858,[],CHEMBL914175,Half life at 75 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,,T1/2,hr,,12.42,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,12.42
48263,,,1869923,[],CHEMBL914183,Half life at 800 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,634949,=,1,1,=,,T1/2,hr,,12.4,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,12.4
48264,,,1870000,[],CHEMBL916616,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 32 after 24 to 48 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
48265,,,1870001,[],CHEMBL915674,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 32 after 72 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.19
48266,,,1870002,[],CHEMBL916618,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 32 after 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.75
48267,,,1870003,[],CHEMBL916619,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 63 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
48268,,,1870004,[],CHEMBL916620,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 114 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
48269,,,1870005,[],CHEMBL916621,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 236 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
48270,,,1870006,[],CHEMBL916622,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 449 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
48271,,,1870007,[],CHEMBL916623,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 16 after 24 to 48 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
48272,,,1870008,[],CHEMBL916624,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 24 after 24 to 48 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
48273,,,1870009,[],CHEMBL916625,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 31 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
48274,,,1870010,[],CHEMBL916626,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S81Y mutation at fAUC/MIC of 16 after 72 hrs in pharmacodynamic model",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,4.0
48275,,,1870011,[],CHEMBL916627,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S81Y mutation at fAUC/MIC of 16 after 96 hrs in pharmacodynamic model",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,4.0
48276,,,1870012,[],CHEMBL916628,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S114G mutation at fAUC/MIC of 24 after 72 hrs in pharmacodynamic model",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.38
48277,,,1870013,[],CHEMBL916089,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S114G mutation at fAUC/MIC of 24 after 96 hrs in pharmacodynamic model",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.5
48278,,,1870014,[],CHEMBL914153,Susceptibility of Streptococcus pneumoniae ATCC 49619 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.025
48279,,,1870015,[],CHEMBL914732,Susceptibility of Streptococcus pneumoniae BSP-2443 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634949,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.025
48280,,,1870057,[],CHEMBL914190,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 200 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634949,=,1,0,=,,fAUC/MIC,,,114.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,114.0
48281,,,1870064,[],CHEMBL915678,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 100 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634949,=,1,0,=,,fAUC/MIC,,,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,31.0
48282,,,1870116,[],CHEMBL914731,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 800 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,634949,=,1,0,=,,fAUC/MIC,,,449.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,449.0
48283,,,2060116,[],CHEMBL926687,Oral bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141299,Bioorg Med Chem,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,684021,=,1,1,=,,F,%,,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,90.0
48284,,,2123032,[],CHEMBL936035,Antimicrobial activity against Bacteroides fragilis isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,1.83,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,1.83
48285,,,2123033,[],CHEMBL936035,Antimicrobial activity against Bacteroides fragilis isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,8.0
48286,,,2123044,[],CHEMBL936957,Antimicrobial activity against Bacteroides distasonis isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,2.32,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC,ug ml-1,UO_0000274,,2.32
48287,,,2123045,[],CHEMBL936957,Antimicrobial activity against Bacteroides distasonis isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC90,ug ml-1,UO_0000274,,16.0
48288,,,2123055,[],CHEMBL936958,Antimicrobial activity against Bacteroides ovatus isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,5.49,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC,ug ml-1,UO_0000274,,5.49
48289,,,2123056,[],CHEMBL936958,Antimicrobial activity against Bacteroides ovatus isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48290,,,2123065,[],CHEMBL936959,Antimicrobial activity against Bacteroides thetaiotaomicron isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,3.71,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,3.71
48291,,,2123066,[],CHEMBL936959,Antimicrobial activity against Bacteroides thetaiotaomicron isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48292,,,2123077,[],CHEMBL936960,Antimicrobial activity against Bacteroides uniformis isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,5.57,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC,ug ml-1,UO_0000274,,5.57
48293,,,2123078,[],CHEMBL936960,Antimicrobial activity against Bacteroides uniformis isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48294,,,2123089,[],CHEMBL936961,Antimicrobial activity against Bacteroides vulgatus isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,7.92,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,7.92
48295,,,2123090,[],CHEMBL936961,Antimicrobial activity against Bacteroides vulgatus isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC90,ug ml-1,UO_0000274,,64.0
48296,,,2123101,[],CHEMBL936962,Antimicrobial activity against Bacteroides caccae isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,3.85,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC,ug ml-1,UO_0000274,,3.85
48297,,,2123102,[],CHEMBL936962,Antimicrobial activity against Bacteroides caccae isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48298,,,2123113,[],CHEMBL936963,Antimicrobial activity against Bacteroides eggerthii isolates by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,3.85,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,3.85
48299,,,2123114,[],CHEMBL936963,Antimicrobial activity against Bacteroides eggerthii isolates by agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
48300,,,2123125,[],CHEMBL936964,Antimicrobial activity against Bacteroides stercoris isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,3.85,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,,MIC,ug ml-1,UO_0000274,,3.85
48301,,,2123126,[],CHEMBL936964,Antimicrobial activity against Bacteroides stercoris isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48302,,,2123137,[],CHEMBL936965,Antimicrobial activity against Bacteroides merdae isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC,ug.mL-1,,3.85,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC,ug ml-1,UO_0000274,,3.85
48303,,,2123138,[],CHEMBL936965,Antimicrobial activity against Bacteroides merdae isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702852,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48304,,,2123148,[],CHEMBL936966,Antimicrobial activity against Bacteroides fragilis assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,27.3,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,Activity,%,UO_0000187,,27.3
48305,,,2123154,[],CHEMBL936967,Antimicrobial activity against Bacteroides distasonis assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,29.2,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,Activity,%,UO_0000187,,29.2
48306,,,2123160,[],CHEMBL936968,Antimicrobial activity against Bacteroides ovatus assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,38.3,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,Activity,%,UO_0000187,,38.3
48307,,,2123165,[],CHEMBL936969,Antimicrobial activity against Bacteroides thetaiotaomicron assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,26.3,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,Activity,%,UO_0000187,,26.3
48308,,,2123171,[],CHEMBL936970,Antimicrobial activity against Bacteroides uniformis assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,38.6,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,Activity,%,UO_0000187,,38.6
48309,,,2123177,[],CHEMBL936971,Antimicrobial activity against Bacteroides vulgatus assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,54.7,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,Activity,%,UO_0000187,,54.7
48310,,,2123183,[],CHEMBL936972,Antimicrobial activity against Bacteroides caccae assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,36.4,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,Activity,%,UO_0000187,,36.4
48311,,,2123189,[],CHEMBL936973,Antimicrobial activity against Bacteroides eggerthii assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,36.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,36.4
48312,,,2123195,[],CHEMBL936974,Antimicrobial activity against Bacteroides merdae assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,36.4,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,Activity,%,UO_0000187,,36.4
48313,,,2123201,[],CHEMBL936034,Antimicrobial activity against Bacteroides stercoris assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,702852,=,1,0,=,,Activity,%,,36.4,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,,Activity,%,UO_0000187,,36.4
48314,,,2124467,[],CHEMBL953034,Inhibition of Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as inhibition of pBR322 DNA supercoiling,B,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704408,=,1,1,=,,IC50,ug.mL-1,,2.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,2.0
48315,,,2124480,[],CHEMBL953035,Effect on Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as enhancement of supercoiled pBR322 DNA cleavage,B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704408,=,1,0,=,,CC25,ug ml-1,,2.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,2.0
48316,,Not Determined,2124493,[],CHEMBL953036,Antibacterial activity against Mycobacterium leprae at 5 ug/mL after 11 to 18 days,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,704408,,1,0,,,Activity,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,,,,
48317,,,2124496,[],CHEMBL953038,Antibacterial activity in Mycobacterium leprae infected mouse foot-pad model assessed as parasite killing at 150 mg/kg/day after 9 months,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,704408,>,1,0,>,,Activity,%,,99.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,%,UO_0000187,,99.0
48318,,,2126517,[],CHEMBL935009,Antimicrobial activity against Streptococcus pneumoniae WB4 by broth macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143816,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702324,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.12
48319,,,2127570,[],CHEMBL938262,Antibacterial activity against Peptostreptococcus anaerobius,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703548,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC50,ug ml-1,UO_0000274,,0.125
48320,,,2127571,[],CHEMBL938262,Antibacterial activity against Peptostreptococcus anaerobius,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703548,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC90,ug ml-1,UO_0000274,,0.125
48321,,,2127582,[],CHEMBL938263,Antibacterial activity against Peptostreptococcus stomatis,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703548,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.125
48322,,,2127583,[],CHEMBL938263,Antibacterial activity against Peptostreptococcus stomatis,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703548,=,1,1,=,,MIC50,ug.mL-1,,0.094,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.094
48323,,,2127741,[],CHEMBL938381,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
48324,,,2127742,[],CHEMBL938381,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MPC,ug ml-1,UO_0000274,,32.0
48325,,,2127745,[],CHEMBL938382,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae UAB1 GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
48326,,,2127747,[],CHEMBL938383,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
48327,,,2127748,[],CHEMBL938383,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MPC,ug ml-1,UO_0000274,,16.0
48328,,,2127751,[],CHEMBL938384,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae N5 GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
48329,,,2127753,[],CHEMBL951356,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae1960 GyrA Ser83Phe mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
48330,,,2127754,[],CHEMBL951356,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae1960 GyrA Ser83Phe mutant expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MPC,ug ml-1,UO_0000274,,32.0
48331,,,2127757,[],CHEMBL951357,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1960 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
48332,,,2127759,[],CHEMBL951358,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
48333,,,2127760,[],CHEMBL951358,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MPC,ug ml-1,UO_0000274,,32.0
48334,,,2127763,[],CHEMBL951359,Antimicrobial activity against qnrA1 expressing Klebsiella pneumoniae 1132 GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
48335,,,2127765,[],CHEMBL951360,Antimicrobial activity against Escherichia coli DH10B expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48336,,,2127766,[],CHEMBL951360,Antimicrobial activity against Escherichia coli DH10B expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MPC,ug ml-1,UO_0000274,,0.06
48337,,,2127769,[],CHEMBL951361,Antimicrobial activity against Escherichia coli DH10B GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
48338,,,2127771,[],CHEMBL951362,Antimicrobial activity against Escherichia coli DH10B/pACYC184 expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48339,,,2127772,[],CHEMBL951362,Antimicrobial activity against Escherichia coli DH10B/pACYC184 expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MPC,ug ml-1,UO_0000274,,0.06
48340,,,2127775,[],CHEMBL952170,Antimicrobial activity against Escherichia coli DH10B/pACYC184 GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
48341,,,2127777,[],CHEMBL952171,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
48342,,,2127778,[],CHEMBL952171,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MPC,ug ml-1,UO_0000274,,2.0
48343,,,2127781,[],CHEMBL952172,Antimicrobial activity against qnrA1 expressing Escherichia coli DH10B GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
48344,,,2127783,[],CHEMBL952173,Antimicrobial activity against Escherichia coli J53 expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
48345,,,2127784,[],CHEMBL952173,Antimicrobial activity against Escherichia coli J53 expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MPC,ug ml-1,UO_0000274,,0.125
48346,,,2127787,[],CHEMBL952174,Antimicrobial activity against Escherichia coli J53 GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
48347,,,2127789,[],CHEMBL952175,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
48348,,,2127790,[],CHEMBL952175,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MPC,ug ml-1,UO_0000274,,4.0
48349,,,2127793,[],CHEMBL952176,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pMG252 GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
48350,,,2127795,[],CHEMBL952177,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
48351,,,2127796,[],CHEMBL952177,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MPC,ug ml-1,UO_0000274,,4.0
48352,,,2127799,[],CHEMBL952178,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/pN5 GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
48353,,,2127801,[],CHEMBL952179,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
48354,,,2127802,[],CHEMBL952179,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MPC,ug ml-1,UO_0000274,,4.0
48355,,,2127805,[],CHEMBL952180,Antimicrobial activity against qnrA1 expressing Escherichia coli J53/p1960 GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
48356,,,2127807,[],CHEMBL952181,Antimicrobial activity against Escherichia coli J53/p1132 negative expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
48357,,,2127808,[],CHEMBL952181,Antimicrobial activity against Escherichia coli J53/p1132 negative expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MPC,ug ml-1,UO_0000274,,0.25
48358,,,2127811,[],CHEMBL952182,Antimicrobial activity against Escherichia coli J53/p1132 negative GyrA/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
48359,,,2127813,[],CHEMBL952183,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
48360,,,2127814,[],CHEMBL952183,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe mutant expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MPC,ug ml-1,UO_0000274,,4.0
48361,,,2127817,[],CHEMBL952184,Antimicrobial activity against Klebsiella pneumoniae C2 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
48362,,,2127819,[],CHEMBL952185,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
48363,,,2127820,[],CHEMBL952185,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe mutant expressing porins by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,0,=,,MPC,ug ml-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MPC,ug ml-1,UO_0000274,,32.0
48364,,,2127823,[],CHEMBL952186,Antimicrobial activity against Klebsiella pneumoniae C2/pMG252 GyrA Ser83Phe/ParC mutant expressing porins by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144466,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703774,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
48365,,,2345554,[],CHEMBL955639,Antimicrobial activity against Vibrio splendidus 12B01 expressing plasmid-mediated QnrS-like quinolone resistance determinants,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613176,Vibrio splendidus,Vibrio splendidus,29497.0,,,MIC,ug ml-1,UO_0000274,,0.25
48366,,,2345555,[],CHEMBL955640,Antimicrobial activity against Vibrio splendidus LGP32 expressing plasmid-mediated QnrS-like quinolone resistance determinants,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613176,Vibrio splendidus,Vibrio splendidus,29497.0,,,MIC,ug ml-1,UO_0000274,,0.25
48367,,,2345556,[],CHEMBL956419,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS1 expressing quinolone resistant Vibrio splendidus 12B01 QnrVS1 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
48368,,,2345557,[],CHEMBL956420,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS2 expressing quinolone resistant Vibrio splendidus LGP32 QnrVS2 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
48369,,,2345558,[],CHEMBL956421,Antimicrobial activity against Escherichia coli TOP10 harbouring pS1 plasmid expressing quinolone resistant QnrS1 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
48370,,,2345559,[],CHEMBL956422,Antimicrobial activity against Escherichia coli TOP10 harbouring pS2 plasmid expressing quinolone resistant QnrS2 gene,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
48371,,,2345560,[],CHEMBL956423,Antimicrobial activity against Escherichia coli TOP10 harbouring p0 plasmid expressing pCR-BluntII-TOPO,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,<,1,1,<,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
48372,,,2345561,[],CHEMBL956424,Antimicrobial activity against Escherichia coli TOP10,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793431,<,1,1,<,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
48373,,,2347410,[],CHEMBL957902,Antibacterial activity against Escherichia coli C600Rif by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.064
48374,,,2347417,[],CHEMBL957904,Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.032
48375,,,2347424,[],CHEMBL957905,Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.032
48376,,,2347431,[],CHEMBL957906,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.094
48377,,,2347438,[],CHEMBL957907,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.032
48378,,,2347445,[],CHEMBL957908,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
48379,,,2347452,[],CHEMBL957909,Antibacterial activity against Escherichia coli TOP10 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
48380,,,2347459,[],CHEMBL957910,Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48381,,,2347466,[],CHEMBL957911,Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48382,,,2347473,[],CHEMBL957912,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
48383,,,2347480,[],CHEMBL957913,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48384,,,2347487,[],CHEMBL957914,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48385,,,2347494,[],CHEMBL957915,Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
48386,,,2347501,[],CHEMBL957916,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48387,,,2347508,[],CHEMBL957917,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793358,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48388,,,2348396,[],CHEMBL957952,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
48389,,,2348397,[],CHEMBL957953,Antibacterial activity against Staphylococcus aureus ACH-0204 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
48390,,,2348398,[],CHEMBL957954,Antibacterial activity against Staphylococcus aureus ACH-0206 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
48391,,,2348399,[],CHEMBL957955,Antibacterial activity against Staphylococcus aureus ACH-0221 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
48392,,,2348400,[],CHEMBL957956,Antibacterial activity against Staphylococcus aureus ACH-0216 isolate with grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
48393,,,2348401,[],CHEMBL957963,"Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
48394,,,2348402,[],CHEMBL957961,"Antibacterial activity against Staphylococcus aureus ACH-0192 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
48395,,,2348403,[],CHEMBL957957,Antibacterial activity against Staphylococcus aureus ACH-0218 isolate with grlA Glu84Lys mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
48396,,,2348404,[],CHEMBL957958,Antibacterial activity against Staphylococcus aureus ACH-0126 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
48397,,,2348405,[],CHEMBL957959,Antibacterial activity against Staphylococcus aureus ACH-0210 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
48398,,,2348406,[],CHEMBL957960,"Antibacterial activity against Staphylococcus aureus ACH-0186 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
48399,,,2348407,[],CHEMBL957962,"Antibacterial activity against Staphylococcus aureus ACH-0203 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
48400,,,2348408,[],CHEMBL957964,"Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
48401,,,2348409,[],CHEMBL954764,"Antibacterial activity against Staphylococcus aureus ACH-0201 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
48402,,,2348410,[],CHEMBL954765,"Antibacterial activity against Staphylococcus aureus ACH-0141 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
48403,,,2348411,[],CHEMBL957214,Antibacterial activity against Staphylococcus aureus ATCC 33591 isolate after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
48404,,,2348412,[],CHEMBL957215,Antibacterial activity against Staphylococcus aureus NY2746 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
48405,,,2348413,[],CHEMBL957216,"Antibacterial activity against Staphylococcus aureus ATCC 700699 isolate with gyrA Ser84Leu, Glu409Lys and grlA Ser80Phe mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
48406,,,2348414,[],CHEMBL957217,"Antibacterial activity against Staphylococcus aureus BSA643 isolate with gyrA Ser84Leu and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
48407,,,2348415,[],CHEMBL957218,"Antibacterial activity against Staphylococcus aureus BSA678 isolate with gyrA Ser84Leu, Ser85Pro and grlA Ser80Phe, Glu84Gly mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
48408,,,2348416,[],CHEMBL957219,"Antibacterial activity against Staphylococcus aureus ACH-0231 isolate with gyrA Ser84Leu, Glu88Lys and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793359,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
48409,,,2348452,[],CHEMBL957238,Inhibition of Staphylococcus aureus wild-type DNA gyrase supercoiling activity assessed as effect on conversion of relaxed pBR322 DNA to supercoiled form,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,"{'bei': '11.36', 'le': '0.21', 'lle': '2.19', 'sei': '5.44'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.56,0,http://www.openphacts.org/units/Nanomolar,793359,=,1,1,=,,IC50,nM,,27500.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,27.5
48410,,,2348453,[],CHEMBL957239,Inhibition of Staphylococcus aureus DNA gyrase gyrA S84L mutant supercoiling activity assessed as effect on conversion of relaxed pBR322 DNA to supercoiled form,B,P20831,S84L,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,793359,=,1,1,=,,IC50,nM,,227000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,IC50,uM,UO_0000065,,227.0
48411,,,2348454,[],CHEMBL957240,Inhibition of Staphylococcus aureus wild-type topoisomerase 4 decatenation activity assessed as unlinking of DNA microcircles from kinetoplast DNA,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.0,0,http://www.openphacts.org/units/Nanomolar,793359,=,1,1,=,,IC50,nM,,1000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,1.0
48412,,,2348455,[],CHEMBL957241,Inhibition of Staphylococcus aureus wild-type topoisomerase 4 grlA S80F mutant decatenation activity assessed as unlinking of DNA microcircles from kinetoplast DNA,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.92,0,http://www.openphacts.org/units/Nanomolar,793359,=,1,1,=,,IC50,nM,,11900.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,11.9
48413,,,2348487,[],CHEMBL960519,Antibacterial activity against Escherichia coli TOP10 containing pS1A plasmid expressing quinolone resistance determinant QnrB4 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793030,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
48414,,,2348496,[],CHEMBL960520,Antibacterial activity against Enterobacter cloacae S1 isolate expressing quinolone resistance determinant QnrB4 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793030,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,32.0
48415,,,2348500,[],CHEMBL960517,Antibacterial activity against Escherichia coli TOP10 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793030,<,1,1,<,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
48416,,,2348503,[],CHEMBL960518,Antibacterial activity against Escherichia coli TOP10 containing pS1B plasmid expressing quinolone resistance determinant QnrS1 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793030,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
48417,,,2351634,[],CHEMBL954735,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792939,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.12
48418,,,2351635,[],CHEMBL954735,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792939,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48419,,,2351649,[],CHEMBL954736,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,792939,=,1,0,=,,Activity,%,,97.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,97.9
48420,,,2351658,[],CHEMBL954737,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolates assessed as percent resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157371,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,792939,=,1,0,=,,Activity,%,,1.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,1.7
48421,,,2358293,[],CHEMBL954102,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1150324,Bioorg Med Chem,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://www.openphacts.org/units/Nanomolar,767230,=,1,1,=,,IC50,nM,,128824.96,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.89
48422,,,2421524,[],CHEMBL955097,"Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as bacterial load per culture-positive foot-pad at 100 mg/kg, po administered for 5 days per week measured after 4 weeks",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,782877,=,1,0,=,,log10cfu,,,3.23,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,,log10cfu,,,,3.23
48423,,,2421528,[],CHEMBL955095,Antimycobacterial activity against Mycobacterium ulcerans isolate CU001,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,782877,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,,MIC,ug ml-1,UO_0000274,,0.25
48424,,,2421533,[],CHEMBL955870,"Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as bacterial load at 100 mg/kg, po administered for 5 days per week measured after 4 weeks",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,782877,=,1,0,=,,log10cfu,,,2.99,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,,log10cfu,,,,2.99
48425,,,2421534,[],CHEMBL955868,"Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as bacterial load per culture-positive foot-pad at 10 mg/kg, po administered for 5 days per week measured after 8 weeks",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,782877,=,1,0,=,,log10cfu,,,1.72,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,,log10cfu,,,,1.72
48426,,,2421535,[],CHEMBL955874,"Antimycobacterial activity against Mycobacterium ulcerans isolate CU001 infected in BALB/c mouse left hind foot-pad assessed as bacterial load at 100 mg/kg, po administered for 5 days per week measured after 8 weeks",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153834,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,782877,=,1,0,=,,log10cfu,,,1.25,CHEMBL612965,Mycobacterium ulcerans,Mycobacterium ulcerans,1809.0,,,log10cfu,,,,1.25
48427,,,2467389,[],CHEMBL991709,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142457,Bioorg Med Chem,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,801575,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
48428,,Not Active,2467408,[],CHEMBL992515,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 2 days before bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142457,Bioorg Med Chem,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,801575,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
48429,,Not Active,2467409,[],CHEMBL993351,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 1 hr before bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142457,Bioorg Med Chem,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,801575,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
48430,,Not Active,2467412,[],CHEMBL993352,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 24 hrs after bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142457,Bioorg Med Chem,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,801575,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
48431,,,2469840,[],CHEMBL983526,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142491,J Med Chem,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,801617,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
48432,,Active,2469856,[],CHEMBL1025786,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 1 hr after bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142491,J Med Chem,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,801617,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
48433,,,2469861,[],CHEMBL1025778,Binding affinity to bone assessed as drug level bound to cattle bone meal powder by fluorescence assay,B,,,BAO_0001103,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142491,J Med Chem,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,801617,=,1,0,=,,Activity,%,,0.01,CHEMBL4296530,Bos taurus,Bone,9913.0,,,Activity,%,UO_0000187,,0.01
48434,,,2495058,[],CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,<=,1,1,<=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48435,,,2495059,[],CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,<=,1,1,<=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48436,,,2495063,[],CHEMBL1028013,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,779483,=,1,0,=,,Activity,%,,2.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,2.4
48437,,,2495079,[],CHEMBL1028014,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by CLSI breakpoint method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,>=,1,0,>=,,Activity,ug ml-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,4.0
48438,,,2495089,[],CHEMBL1028015,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent sensitive isolates by CLSI breakpoint method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,<=,1,0,<=,,Activity,ug ml-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,1.0
48439,,,2495096,[],CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779483,>,1,1,>,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48440,,,2498185,[],CHEMBL1030565,Antibacterial activity against Staphylococcus aureus RN4220 by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.064
48441,,,2498186,[],CHEMBL1030566,Antibacterial activity against Staphylococcus aureus RN4220 containing ORI23 promoter by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.064
48442,,,2498187,[],CHEMBL1030567,Antibacterial activity against Staphylococcus aureus RN4220 containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
48443,,,2498188,[],CHEMBL1030568,Antibacterial activity against Lactococcus lactis IL-1419 by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,,MIC,ug ml-1,UO_0000274,,0.25
48444,,,2498189,[],CHEMBL1033151,Antibacterial activity against Lactococcus lactis IL-1419 containing ORI23 promoter by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,,MIC,ug ml-1,UO_0000274,,0.25
48445,,,2498190,[],CHEMBL1020335,Antibacterial activity against Lactococcus lactis IL-1419 containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613069,Lactococcus lactis,Lactococcus lactis,1358.0,,,MIC,ug ml-1,UO_0000274,,1.0
48446,,,2498191,[],CHEMBL1020336,Antibacterial activity against Escherichia coli DH10B by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48447,,,2498192,[],CHEMBL1020337,Antibacterial activity against Escherichia coli DH10B containing ORI23 promoter by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48448,,,2498193,[],CHEMBL1020338,Antibacterial activity against Escherichia coli DH10B containing ORI23::qnr-cat promoter mutant by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154420,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779315,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.032
48449,,,2499758,[],CHEMBL992264,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
48450,,,2499780,[],CHEMBL992265,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48451,,,2499802,[],CHEMBL992266,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
48452,,,2499824,[],CHEMBL992267,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48453,,,2499846,[],CHEMBL992268,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
48454,,,2499868,[],CHEMBL992269,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779190,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
48455,,,2499890,[],CHEMBL992270,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,779190,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
48456,,,2502729,[],CHEMBL1029671,"Half life in human serum at 400 mg, po administered as single dose",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,780040,=,1,1,=,,T1/2,hr,,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,8.0
48457,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2502730,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1029672,"Cmax in human serum at 400 mg, po administered as single dose after 1 hr",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,780040,=,1,1,=,,Cmax,nM,,6227.58,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,mg/L,UO_0000065,,2.5
48458,,,2502731,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1029673,"AUC (0 to 24 hrs) in human serum at 400 mg, po administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,780040,=,1,1,=,,AUC,ng.hr.mL-1,,35000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,mg.hr/L,,,35.0
48459,,,2502732,[],CHEMBL1029674,Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780040,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
48460,,,2502733,[],CHEMBL1029675,Antibacterial activity against methicillin-sensitive Staphylococcus aureus by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780040,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.032
48461,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2502734,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '45.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '45.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1029676,"Cmax in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,780040,=,1,1,=,,Cmax,nM,,7099.44,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmax,mg/L,UO_0000065,,2.85
48462,,,2502735,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '45.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '45.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1029677,"AUC (0 to 24 hrs) in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,780040,=,1,1,=,,AUC,ng.hr.mL-1,,37500.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,mg.hr/L,,,37.5
48463,,,2502736,[],CHEMBL1029678,"Half life in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,780040,=,1,1,=,,T1/2,hr,,8.2,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,t1/2,hr,UO_0000032,,8.2
48464,,,2502737,[],CHEMBL1029679,"Ratio of AUC (0 to 24 hrs) in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po to MIC for methicillin-sensitive Staphylococcus aureus",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,780040,>,1,0,>,,RatioAUC/MIC,,,1000.0,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,1000.0
48465,,,2502738,[],CHEMBL1029680,"Ratio of Cmax in Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po to MIC for methicillin-sensitive Staphylococcus aureus",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,780040,=,1,0,=,,Ratio,,,90.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,90.0
48466,,,2502739,[],CHEMBL1029681,"Cmin in synovial fluid of Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po after 7 days",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,780040,=,1,0,=,,Cmin,mg/L,,3.9,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmin,mg/L,,,3.9
48467,,,2502740,[],CHEMBL1029682,"Ratio of Cmin in synovial fluid of Staphylococcus aureus infected rabbit arthritis model at 45 mg/kg, po to MIC for methicillin-sensitive Staphylococcus aureus",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,780040,=,1,0,=,,Ratio,,,121.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,121.0
48468,,,2502741,[],CHEMBL1029685,"Antibacterial activity against methicillin-sensitive Staphylococcus aureus infected rabbit arthritis model assessed as change in bacterial load per gram of synovial fluid at 45 mg/kg, po after 7 days by broth microdilution technique",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,780040,=,1,0,=,,deltalog10CFU,,,4.34,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,4.34
48469,,,2502742,[],CHEMBL1029684,"Antibacterial activity against methicillin-resistant Staphylococcus aureus infected rabbit arthritis model assessed as change in bacterial load per gram of synovial fluid at 45 mg/kg, po after 7 days by broth microdilution technique",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,780040,=,1,0,=,,deltalog10CFU,,,4.47,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU,,,,4.47
48470,,,2502743,[],CHEMBL1029688,Antibacterial activity against ciprofloxacin and methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780040,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
48471,,,2502744,[],CHEMBL1029689,"Cmax in human serum at 400 mg, po administered as single dose",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143423,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,780040,=,1,0,=,,tCmax,hr,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,tCmax,hr,UO_0000032,,1.0
48472,,Active,2556436,[],CHEMBL993693,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48473,,Active,2556439,[],CHEMBL993692,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48474,,,2556468,[],CHEMBL990922,Antimicrobial activity against nonepidemic Clostridium difficile ATCC 9689 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,<,1,1,<,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
48475,,,2556473,[],CHEMBL990923,Antimicrobial activity against nonepidemic Clostridium difficile J29 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
48476,,,2556478,[],CHEMBL990924,Antimicrobial activity against epidemic Clostridium difficile BI9 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
48477,,,2556483,[],CHEMBL990925,Antimicrobial activity against epidemic Clostridium difficile BI6-8-17 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
48478,,,2556488,[],CHEMBL990926,Antimicrobial activity against fluoroquinolone-resistant epidemic Clostridium difficile NAP1 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,256.0
48479,,,2556493,[],CHEMBL990927,Antimicrobial activity against fluoroquinolone-susceptible nonepidemic Clostridium difficile strain6 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743672,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
48480,,Active,2556501,[],CHEMBL994406,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48481,,Active,2556502,[],CHEMBL994407,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48482,,Active,2556504,[],CHEMBL994409,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48483,,Active,2556521,[],CHEMBL994410,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48484,,Active,2556522,[],CHEMBL994411,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48485,,Active,2556523,[],CHEMBL994412,"Effect on growth of epidemic Clostridium difficile BI9 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48486,,Active,2556524,[],CHEMBL994413,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48487,,Active,2556525,[],CHEMBL994414,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48488,,Active,2556526,[],CHEMBL994415,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48489,,Active,2556527,[],CHEMBL994417,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48490,,,2556544,[],CHEMBL993691,Drug level in Clostridium difficile infected CF1 mouse stool at 0.2 mg/day for 4 days,A,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,=,1,0,=,,Drug uptake,ug/g,,44.0,CHEMBL612558,,ADMET,,,,Drug uptake,ug/g,,,44.0
48491,,Not Active,2556557,[],CHEMBL993695,Effect on growth of fluoroquinolone-susceptible epidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content dosed sc for 5 days,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48492,,Active,2556588,[],CHEMBL993694,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 2.0 mg/day, sc for 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743672,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
48493,,,2575481,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '12.0'}]",CHEMBL994364,"AUC (0 to 12 hrs) in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit at 20 mg/kg, iv administered every 12 hrs measured after seventh dose in presence of Dexamethasone",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,1,=,,AUC,ng.hr.mL-1,,23900.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,microg.hr/mL,,,23.9
48494,,,2575482,[],CHEMBL994369,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as fibrous content median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Activity,,,1.6,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,,,,1.6
48495,,,2575483,[],CHEMBL994366,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as tissue valve damage median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Activity,,,2.3,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,,,,2.3
48496,,,2575484,[],CHEMBL994368,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as collagenization median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Activity,,,2.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,,,,2.0
48497,,,2575485,[],CHEMBL994370,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as calcification median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Activity,,,1.6,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,,,,1.6
48498,,,2575486,[],CHEMBL994367,"Toxicity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as inflammatory cell infiltration median score at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose by histopathology",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Activity,,,1.2,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,,,,1.2
48499,,Active,2575487,[],CHEMBL994365,"Cardiovascular activity in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit assessed as increase in fractional shortening at 20 mg/kg, iv administered every 12 hrs for 5 days by ECG",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
48500,,,2575492,[],CHEMBL993606,Antibacterial activity against Staphylococcus aureus by manual microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743503,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
48501,,,2575493,[],CHEMBL993606,Antibacterial activity against Staphylococcus aureus by manual microdilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,MBC,mg/L,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/L,,,0.125
48502,,,2575494,[],CHEMBL993608,Antibacterial activity against Staphylococcus aureus by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743503,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.064
48503,,,2575495,[],CHEMBL993607,Antibacterial activity against Staphylococcus aureus at 0.5 mg/liter by time kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,>,1,0,>,,log10CFU/ml,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.0
48504,,,2575496,[],CHEMBL993609,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as number of survival days at 20 mg/kg, iv administered every 12 hrs for 5 days",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Day,743503,=,1,0,=,,Survival,day,,15.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Survival,day,UO_0000033,,15.3
48505,,,2575497,[],CHEMBL993611,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as reduction in bacterial burdens in blood culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 hrs after end of treatment",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,log10CFU/ml,,,2.83,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.83
48506,,Active,2575498,[],CHEMBL993612,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as cured animals in blood culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
48507,,Active,2575499,[],CHEMBL993610,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as cured animals in blood culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 hrs after end of treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
48508,,,2575500,[],CHEMBL993613,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as reduction in bacterial burdens in blood culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,log10CFU/ml,mg/L,,2.76,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,mg/L,,,2.76
48509,,,2575501,[],CHEMBL994358,"Concentration in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 30 mins after third dose",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Drug uptake,mg/L,,3.73,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Drug uptake,mg/L,,,3.73
48510,,,2575502,[],CHEMBL994359,"Concentration in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 12 hrs after third dose",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Drug uptake,mg/L,,0.23,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Drug uptake,mg/L,,,0.23
48511,,,2575503,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '12.0'}]",CHEMBL994360,"AUC (0 to 12 hrs) in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit at 20 mg/kg, iv administered every 12 hrs measured after third dose",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,1,=,,AUC,ng.hr.mL-1,,16500.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,mg.hr/L,,,16.5
48512,,,2575504,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '12.0'}]",CHEMBL994361,"AUC (0 to 12 hrs) in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit at 20 mg/kg, iv administered every 12 hrs measured after seventh dose",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,1,=,,AUC,ng.hr.mL-1,,22200.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,mg.hr/L,,,22.2
48513,,,2575505,[],CHEMBL994362,"Concentration in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 30 mins after seventh dose in presence of Dexamethasone",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Drug uptake,mg/L,,3.33,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Drug uptake,mg/L,,,3.33
48514,,,2575506,[],CHEMBL994363,"Concentration in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 12hrs after seventh dose in presence of Dexamethasone",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Drug uptake,mg/L,,1.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Drug uptake,mg/L,,,1.0
48515,,,2575507,[],CHEMBL993614,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as reduction in bacterial burdens in heart valve tissue culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 hrs after end of treatment",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,log10CFU/g,,,2.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,2.1
48516,,,2575508,[],CHEMBL993615,"Antibacterial activity against Staphylococcus aureus infection-induced aortic valve endocarditis in rabbit assessed as reduction in bacterial burdens in heart valve tissue culture at 20 mg/kg, iv administered every 12 hrs for 5 days sacrificed 12 days after last dose",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,log10CFU/g,,,2.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,2.2
48517,,,2575509,[],CHEMBL994371,"Drug level in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 30 mins after seventh dose",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Drug uptake,mg/L,,4.39,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Drug uptake,mg/L,,,4.39
48518,,,2575510,[],CHEMBL994372,"Drug level in Staphylococcus aureus infection-induced aortic valve endocarditis rabbit serum at 20 mg/kg, iv administered every 12 hrs measured 12 hrs after seventh dose",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155768,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,743503,=,1,0,=,,Drug uptake,mg/L,,0.51,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Drug uptake,mg/L,,,0.51
48519,,,2576461,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL987311,"AUC (0 to 24 hrs) in human at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg, po once daily",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,742519,=,1,1,=,,AUC,ng.hr.mL-1,,29200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,29.2
48520,,,2576462,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL987312,"AUC (0 to 24 hrs) in human at 400 mg, po once daily after 4 days",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,742519,=,1,1,=,,AUC,ng.hr.mL-1,,39400.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,39.4
48521,,,2576463,[],CHEMBL987315,"Plasma concentration in human at 400 mg, po once daily after 4 days",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742519,=,1,0,=,,Cp,ug ml-1,,3.8,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.8
48522,,,2576464,[],CHEMBL987318,"Half life in human at 400 mg, po once daily after 4 days",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,T1/2,hr,,10.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,10.4
48523,,,2576465,[],CHEMBL987321,"Tmax in human at 400 mg, po once daily after 4 days",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,Tmax,hr,,1.97,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.97
48524,,,2576466,[],CHEMBL987314,"Plasma concentration in human at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg, po once daily",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742519,=,1,0,=,,Cp,ug ml-1,,3.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.6
48525,,,2576467,[],CHEMBL987317,"Half life in human at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg, po once daily",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,T1/2,hr,,6.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,6.5
48526,,,2576468,[],CHEMBL987320,"Tmax in human at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg, po once daily",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,Tmax,hr,,1.56,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.56
48527,,,2576472,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL987322,"AUC (0 to 24 hrs) in human with MDR1 3435 CC genotype at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg/kg, po once daily",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,742519,=,1,1,=,,AUC,ng.hr.mL-1,,25500.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,25.5
48528,,,2576473,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL987323,"AUC (0 to 24 hrs) in human with MDR1 3435 CC or CT genotype at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg/kg, po once daily",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,742519,=,1,1,=,,AUC,ng.hr.mL-1,,30300.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,30.3
48529,,,2576474,[],CHEMBL987326,"Plasma concentration in human with MDR1 3435 CC genotype at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg/kg, po once daily",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742519,=,1,0,=,,Cp,ug ml-1,,2.94,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,2.94
48530,,,2576475,[],CHEMBL987327,"Plasma concentration in human with MDR1 3435 CC or CT genotype at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg/kg, po once daily",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742519,=,1,0,=,,Cp,ug ml-1,,3.83,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.83
48531,,,2576476,[],CHEMBL987330,"Tmax in human with MDR1 3435 CC genotype at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg/kg, po once daily",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,Tmax,hr,,1.98,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.98
48532,,,2576477,[],CHEMBL987331,"Tmax in human with MDR1 3435 CC or CT genotype at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg/kg, po once daily",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,Tmax,hr,,1.05,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.05
48533,,,2576478,[],CHEMBL988153,"Half life in human with MDR1 3435 CC genotype at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg/kg, po once daily",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,T1/2,hr,,6.51,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,6.51
48534,,,2576479,[],CHEMBL988154,"Half life in human with MDR1 3435 CC or CT genotype at 400 mg, po once daily after 14 days coadministered with rifampin at 600 mg/kg, po once daily",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,T1/2,hr,,6.46,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,6.46
48535,,,2576480,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL987324,"AUC (0 to 24 hrs) in human with MDR1 3435 CC genotype at 400 mg, po once daily after 4 days",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,742519,=,1,1,=,,AUC,ng.hr.mL-1,,37200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,37.2
48536,,,2576481,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL987325,"AUC (0 to 24 hrs) in human with MDR1 3435 CC or CT genotype at 400 mg, po once daily after 4 days",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,742519,=,1,1,=,,AUC,ng.hr.mL-1,,39700.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,39.7
48537,,,2576482,[],CHEMBL987328,"Plasma concentration in human with MDR1 3435 CC genotype at 400 mg, po once daily after 4 days",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742519,=,1,0,=,,Cp,ug ml-1,,3.53,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.53
48538,,,2576483,[],CHEMBL987329,"Plasma concentration in human with MDR1 3435 CC or CT genotype at 400 mg, po once daily after 4 days",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742519,=,1,0,=,,Cp,ug ml-1,,3.81,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,3.81
48539,,,2576484,[],CHEMBL987332,"Tmax in human with MDR1 3435 CC genotype at 400 mg, po once daily after 4 days",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,Tmax,hr,,1.47,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.47
48540,,,2576485,[],CHEMBL988152,"Tmax in human with MDR1 3435 CC or CT genotype at 400 mg, po once daily after 4 days",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,Tmax,hr,,1.91,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.91
48541,,,2576486,[],CHEMBL988155,"Half life in human with MDR1 3435 CC genotype at 400 mg, po once daily after 4 days",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,T1/2,hr,,10.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,10.9
48542,,,2576487,[],CHEMBL988156,"Half life in human with MDR1 3435 CC or CT genotype at 400 mg, po once daily after 4 days",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155148,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,742519,=,1,1,=,,T1/2,hr,,9.77,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,9.77
48543,,,2576492,[],CHEMBL988157,Antimicrobial activity against Clostridium difficile clinical isolates by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155149,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743071,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,1.0
48544,,,2576493,[],CHEMBL988157,Antimicrobial activity against Clostridium difficile clinical isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155149,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743071,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,16.0
48545,,,2632653,[],CHEMBL963550,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,6.6,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,6.6
48546,,,2632654,[],CHEMBL963549,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,6.53,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,6.53
48547,,,2632655,[],CHEMBL963548,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,5.35,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,5.35
48548,,,2632674,[],CHEMBL963544,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,4.15,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,log10cfu,,,,4.15
48549,,,2632675,[],CHEMBL963543,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,4.76,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,log10cfu,,,,4.76
48550,,,2632676,[],CHEMBL963542,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,4.83,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,log10cfu,,,,4.83
48551,,,2632677,[],CHEMBL963538,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,9.18,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,9.18
48552,,,2632678,[],CHEMBL963537,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,9.68,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,9.68
48553,,,2632679,[],CHEMBL963536,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,8.83,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,8.83
48554,,,2632686,[],CHEMBL949908,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,7.9,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,7.9
48555,,,2632687,[],CHEMBL998999,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,7.78,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,7.78
48556,,,2632688,[],CHEMBL999000,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,7.39,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,7.39
48557,,,2632698,[],CHEMBL962730,Antimycobacterial activity against Mycobacterium avium JATA51-01 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783317,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,2.0
48558,,,2632699,[],CHEMBL962731,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783317,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,0.5
48559,,,2632700,[],CHEMBL962732,Antimycobacterial activity against Mycobacterium avium complex N016 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783317,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,MIC,ug ml-1,UO_0000274,,0.5
48560,,,2632701,[],CHEMBL962733,Antimycobacterial activity against Mycobacterium avium complex N018 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783317,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,MIC,ug ml-1,UO_0000274,,0.5
48561,,,2632702,[],CHEMBL963534,Antimycobacterial activity against Mycobacterium avium complex N084 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783317,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,MIC,ug ml-1,UO_0000274,,0.5
48562,,,2632718,[],CHEMBL963535,Antimycobacterial activity against Mycobacterium avium complex after 14 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783317,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,MIC90,ug ml-1,UO_0000274,,2.0
48563,,,2632722,[],CHEMBL963554,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,5.79,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,5.79
48564,,,2632723,[],CHEMBL963555,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,7.09,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,7.09
48565,,,2632724,[],CHEMBL949904,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,783317,=,1,0,=,,log10cfu,,,6.6,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,6.6
48566,,,2645541,[],CHEMBL1023674,Inhibition of human ERG in MCF7 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1158373,Eur J Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://www.openphacts.org/units/Nanomolar,814290,=,1,1,=,,IC50,nM,,117489.76,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.93
48567,,,2645578,[],CHEMBL1023675,"Lipophilicity, log D at pH 7.0",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1158373,Eur J Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,814290,=,1,1,=,,LogD,,,-2.9,CHEMBL2362975,,No relevant target,,,,logD,,,,-2.9
48568,,,2659610,[],CHEMBL1051483,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48569,,,2659611,[],CHEMBL1051473,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48570,,,2659612,[],CHEMBL1051468,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48571,,,2659613,[],CHEMBL1051460,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48572,,,2659614,[],CHEMBL1062983,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48573,,,2659615,[],CHEMBL1023504,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48574,,,2659616,[],CHEMBL1023494,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48575,,,2659617,[],CHEMBL1023488,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48576,,,2659618,[],CHEMBL1036288,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48577,,,2659619,[],CHEMBL1036283,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48578,,,2659620,[],CHEMBL1052242,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48579,,,2659621,[],CHEMBL1052246,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48580,,,2659883,[],CHEMBL1051478,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 25 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48581,,,2659884,[],CHEMBL1051477,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 21 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48582,,,2659885,[],CHEMBL1051476,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 18 passages with levofloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48583,,,2659886,[],CHEMBL1051475,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 19 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48584,,,2659887,[],CHEMBL1051470,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48585,,,2659888,[],CHEMBL1051469,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 35 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48586,,,2659889,[],CHEMBL1051464,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 15 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48587,,,2659890,[],CHEMBL1051462,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 29 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48588,,,2659891,[],CHEMBL1051461,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 49 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48589,,,2659892,[],CHEMBL1062986,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48590,,,2659893,[],CHEMBL1062985,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 26 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
48591,,,2659894,[],CHEMBL1062984,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 38 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48592,,,2659895,[],CHEMBL1062979,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48593,,,2660196,[],CHEMBL1062978,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 44 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48594,,,2660197,[],CHEMBL1023505,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48595,,,2660198,[],CHEMBL1023498,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 29 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48596,,,2660199,[],CHEMBL1023497,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 33 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48597,,,2660200,[],CHEMBL1023496,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 41 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48598,,,2660201,[],CHEMBL1023495,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 20 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48599,,,2660202,[],CHEMBL1023490,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48600,,,2660203,[],CHEMBL1052241,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48601,,,2660204,[],CHEMBL1023489,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 49 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48602,,,2660205,[],CHEMBL1023485,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48603,,,2660206,[],CHEMBL1023484,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48604,,,2660207,[],CHEMBL1036285,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 20 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48605,,,2660208,[],CHEMBL1036284,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 14 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48606,,,2660209,[],CHEMBL1036280,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 after 48 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48607,,,2660210,[],CHEMBL1052245,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48608,,,2660211,[],CHEMBL1052249,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 after 30 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48609,,,2660230,[],CHEMBL1051479,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 19 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48610,,,2660232,[],CHEMBL1051471,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 35 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48611,,,2660245,[],CHEMBL1051467,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48612,,,2660248,[],CHEMBL1062987,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 38 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48613,,,2660263,[],CHEMBL1062982,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48614,,,2660267,[],CHEMBL1023499,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 20 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48615,,,2660282,[],CHEMBL1023493,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48616,,,2660288,[],CHEMBL1023487,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48617,,,2660295,[],CHEMBL1036289,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48618,,,2660304,[],CHEMBL1036282,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48619,,,2660310,[],CHEMBL1052243,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48620,,,2660318,[],CHEMBL1052247,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818310,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48621,,,2661943,[],CHEMBL1028802,Antimicrobial activity against Dialister micraerophilus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,MIC50,ug ml-1,UO_0000274,,0.06
48622,,,2662322,[],CHEMBL1023541,Antimicrobial activity against Escherichia coli DH10B expressing pCRQB10 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818896,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
48623,,,2662330,[],CHEMBL1023542,Antimicrobial activity against Escherichia coli DH10B expressing pCR2.1 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818896,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
48624,,,2662338,[],CHEMBL1023543,Antimicrobial activity against Escherichia coli DH10B in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818896,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
48625,,,2662986,[],CHEMBL1028802,Antimicrobial activity against Dialister micraerophilus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,MIC,ug ml-1,UO_0000274,,0.06
48626,,,2663003,[],CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,MIC90,ug ml-1,UO_0000274,,0.06
48627,,,2663020,[],CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,MIC50,ug ml-1,UO_0000274,,0.06
48628,,,2663037,[],CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,MIC,ug ml-1,UO_0000274,,0.06
48629,,,2663060,[],CHEMBL1028802,Antimicrobial activity against Dialister micraerophilus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48630,,,2663108,[],CHEMBL1028805,Antimicrobial activity against Dialister pneumosintes assessed as susceptibility breakpoint by CA-SFM method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,0,<=,,Activity,ug ml-1,,1.0,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,Activity,ug ml-1,UO_0000274,,1.0
48631,,,2663125,[],CHEMBL1028806,Antimicrobial activity against Dialister micraerophilus assessed as susceptibility breakpoint by CA-SFM method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,0,<=,,Activity,ug ml-1,,1.0,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,Activity,ug ml-1,UO_0000274,,1.0
48632,,,2663142,[],CHEMBL1028809,Antimicrobial activity against Dialister propionicifaciens by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,,MIC,ug ml-1,UO_0000274,,0.06
48633,,,2663159,[],CHEMBL1028810,Antimicrobial activity against Dialister invisus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,,MIC,ug ml-1,UO_0000274,,0.06
48634,,,2663176,[],CHEMBL1028811,Antimicrobial activity against Dialister propionicifaciens assessed as susceptibility breakpoint by CLSI method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,0,<=,,Activity,ug ml-1,,2.0,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,,Activity,ug ml-1,UO_0000274,,2.0
48635,,,2663193,[],CHEMBL1028812,Antimicrobial activity against Dialister invisus assessed as susceptibility breakpoint by CLSI method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,0,<=,,Activity,ug ml-1,,2.0,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,,Activity,ug ml-1,UO_0000274,,2.0
48636,,,2663230,[],CHEMBL1028807,Antimicrobial activity against Dialister pneumosintes assessed as susceptibility breakpoint by CLSI-M11-A7 method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,0,<=,,Activity,ug ml-1,,2.0,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,Activity,ug ml-1,UO_0000274,,2.0
48637,,,2663231,[],CHEMBL1028808,Antimicrobial activity against Dialister micraerophilus assessed as susceptibility breakpoint by CLSI-M11-A7 method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,0,<=,,Activity,ug ml-1,,2.0,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,Activity,ug ml-1,UO_0000274,,2.0
48638,,,2663232,[],CHEMBL1028815,Antimicrobial activity against Dialister propionicifaciens assessed as susceptibility breakpoint by CLSI-M11-A7 method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,0,<=,,Activity,ug ml-1,,1.0,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,,Activity,ug ml-1,UO_0000274,,1.0
48639,,,2663233,[],CHEMBL1028816,Antimicrobial activity against Dialister invisus assessed as susceptibility breakpoint by CLSI-M11-A7 method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818320,<=,1,0,<=,,Activity,ug ml-1,,1.0,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,,Activity,ug ml-1,UO_0000274,,1.0
48640,,,2663960,[],CHEMBL1023510,Antimicrobial activity against multidrug-resistant Enterobacter cloacae E705 bearing qnrB10 gene with aac(6)-IId-aadA1a integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818896,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,64.0
48641,,,2663968,[],CHEMBL1023538,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae M7943 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818896,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
48642,,,2663976,[],CHEMBL1023539,Antimicrobial activity against multidrug-resistant Escherichia coli M7943-TC2 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818896,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
48643,,,2663984,[],CHEMBL1023540,Antimicrobial activity against Escherichia coli J53-AzR in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818896,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
48644,,,2666047,[],CHEMBL1063025,Antimicrobial activity against Mycobacterium smegmatis by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152337,J Nat Prod,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,817539,=,1,1,=,,MIC,nM,,700.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,0.7
48645,,,2672126,[],CHEMBL1035433,Total body clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,821073,=,1,1,=,,CL,mL.min-1.kg-1,,2.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,2.4
48646,,,2672127,[],CHEMBL1035434,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,821073,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.53,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,0.53
48647,,,2674021,[],CHEMBL1026151,Antibacterial activity against Streptococcus pneumoniae HMC 3041 after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48648,,,2674035,[],CHEMBL1026148,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48649,,,2674040,[],CHEMBL1026147,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48650,,,2674046,[],CHEMBL1026146,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48651,,,2674052,[],CHEMBL1026145,"Antibacterial activity against penicillin-, quinolone-resistant Streptococcus pneumoniae HMC 1541 harboring mutation in L4 protein by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48652,,,2674058,[],CHEMBL1026144,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
48653,,,2674064,[],CHEMBL1026143,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
48654,,,2674070,[],CHEMBL1026142,"Antibacterial activity against penicillin-, quinolone-resistant and macrolide-susceptible Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48655,,,2674076,[],CHEMBL1031971,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
48656,,,2674082,[],CHEMBL1031970,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 441 expressing ermB by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
48657,,,2674088,[],CHEMBL1031969,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48658,,,2674094,[],CHEMBL1031968,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48659,,,2674100,[],CHEMBL1031967,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48660,,,2674106,[],CHEMBL1031966,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48661,,,2674112,[],CHEMBL1031965,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48662,,,2674118,[],CHEMBL1031964,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48663,,,2674123,[],CHEMBL1031142,"Antibacterial activity against Streptococcus pneumoniae HMC 1068 harboring E85K mutation in quinolone-resistant determining regions of GyrA gene, S79Y, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48664,,,2674129,[],CHEMBL1031141,"Antibacterial activity against Streptococcus pneumoniae HMC 1062 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48665,,,2674135,[],CHEMBL1031140,"Antibacterial activity against Streptococcus pneumoniae HMC 4026 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48666,,,2674141,[],CHEMBL1031139,"Antibacterial activity against Streptococcus pneumoniae HMC 2536 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48667,,,2674147,[],CHEMBL1031138,"Antibacterial activity against Streptococcus pneumoniae HMC 2527 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48668,,,2674153,[],CHEMBL1031137,"Antibacterial activity against Streptococcus pneumoniae HMC 1541 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48669,,,2674159,[],CHEMBL1031136,"Antibacterial activity against Streptococcus pneumoniae HMC 1156 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48670,,,2674165,[],CHEMBL1031135,"Antibacterial activity against Streptococcus pneumoniae HMC 1139 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48671,,,2674171,[],CHEMBL1026129,"Antibacterial activity against Streptococcus pneumoniae HMC 1078 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48672,,,2674177,[],CHEMBL1026128,Antibacterial activity against Streptococcus pneumoniae HMC 1077 harboring S81Y and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48673,,,2674183,[],CHEMBL1026127,"Antibacterial activity against Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48674,,,2674189,[],CHEMBL1026126,"Antibacterial activity against Streptococcus pneumoniae HMC 1072 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48675,,,2674195,[],CHEMBL1026125,"Antibacterial activity against Streptococcus pneumoniae HMC 1071 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and S79F, K137N mutation in QRDR of ParC gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48676,,,2674201,[],CHEMBL1026124,"Antibacterial activity against Streptococcus pneumoniae HMC 1059 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460N mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48677,,,2674207,[],CHEMBL1025290,"Antibacterial activity against Streptococcus pneumoniae HMC 1055 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48678,,,2674213,[],CHEMBL1025289,Antibacterial activity against Streptococcus pneumoniae HMC 5041 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48679,,,2674219,[],CHEMBL1025288,"Antibacterial activity against Streptococcus pneumoniae HMC 2538 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin, gatifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48680,,,2674225,[],CHEMBL1025287,"Antibacterial activity against Streptococcus pneumoniae HMC 1150 harboring S81C mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48681,,,2674231,[],CHEMBL1025286,"Antibacterial activity against Streptococcus pneumoniae HMC 1147 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48682,,,2674237,[],CHEMBL1025285,"Antibacterial activity against Streptococcus pneumoniae HMC 1146 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and D435N mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48683,,,2674243,[],CHEMBL1025284,"Antibacterial activity against Streptococcus pneumoniae HMC 1076 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48684,,,2674249,[],CHEMBL1025283,"Antibacterial activity against Streptococcus pneumoniae HMC 1073 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48685,,,2674255,[],CHEMBL1025282,"Antibacterial activity against Streptococcus pneumoniae HMC 1070 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48686,,,2674261,[],CHEMBL1025281,"Antibacterial activity against Streptococcus pneumoniae HMC 1066 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48687,,,2674267,[],CHEMBL1025280,"Antibacterial activity against Streptococcus pneumoniae HMC 1060 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48688,,,2674926,[],CHEMBL1025279,"Antibacterial activity against Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48689,,,2674932,[],CHEMBL1031123,"Antibacterial activity against Streptococcus pneumoniae HMC 1151 harboring D83N, K137N mutation in quinolone-resistant determining regions of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48690,,,2674938,[],CHEMBL1031122,"Antibacterial activity against Streptococcus pneumoniae HMC 1149 harboring S81F and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48691,,,2674946,[],CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
48692,,,2674955,[],CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,4.0
48693,,,2674964,[],CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48694,,,2674973,[],CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48695,,,2674982,[],CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48696,,,2674991,[],CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48697,,,2675000,[],CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
48698,,,2675009,[],CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48699,,,2675018,[],CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
48700,,,2675027,[],CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48701,,,2675036,[],CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48702,,,2675045,[],CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.12
48703,,,2675054,[],CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48704,,,2675064,[],CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48705,,,2675076,[],CHEMBL1026153,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48706,,,2675081,[],CHEMBL1026154,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae HMC 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48707,,,2675087,[],CHEMBL1026155,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48708,,,2675092,[],CHEMBL1026156,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48709,,,2675098,[],CHEMBL1026974,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 41 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48710,,,2675104,[],CHEMBL1026975,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 42 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48711,,,2675110,[],CHEMBL1026976,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene after 22 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48712,,,2675116,[],CHEMBL1026977,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S79Y mutation in quinolone-resistant determining regions of ParC gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48713,,,2675122,[],CHEMBL1026978,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 28 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48714,,,2675128,[],CHEMBL1026979,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 36 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48715,,,2675134,[],CHEMBL1026980,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 49 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48716,,,2675140,[],CHEMBL1026981,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and I460V, D435N mutation in QRDR of ParE gene after 46 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48717,,,2675146,[],CHEMBL1029503,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring I460V mutation in QRDR of ParE gene after 41 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48718,,,2675152,[],CHEMBL1031996,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F, E85K mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 27 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
48719,,,2675160,[],CHEMBL1031999,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 38 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48720,,,2675166,[],CHEMBL1032774,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 44 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48721,,,2675175,[],CHEMBL1032782,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB after 36 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48722,,,2675178,[],CHEMBL1032785,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 after 22 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48723,,,2675180,[],CHEMBL1032775,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 after 41 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
48724,,,2675215,[],CHEMBL1033609,Antimicrobial activity against avirulent Mycobacterium tuberculosis H37Ra,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819275,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
48725,,,2675216,[],CHEMBL1033600,"AUC in human at 400 mg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,1,=,,AUC,ng.hr.mL-1,,26900.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,microg.hr/mL,,,26.9
48726,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2675217,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1033599,"Cmax in human at 400 mg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,819275,=,1,1,=,,Cmax,nM,,6227.58,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,2.5
48727,,,2675218,[],CHEMBL1032809,AUC (0 to 24 hrs) in CD-1 mouse at 0.41 to 2.2 ug/kg administered through gavage,A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,1,=,,AUC,ng.hr.mL-1,,27400.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,ug.hr/ml,,,27.4
48728,,,2675219,[],CHEMBL1033598,Drug level in CD-1 mouse serum at 75 ug/ml administered through gavage after 24 hrs,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819275,=,1,0,=,,Drug uptake,ug ml-1,,8.0,CHEMBL613590,Mus musculus,Serum,10090.0,,,Drug uptake,ug ml-1,UO_0000274,,8.0
48729,,,2675220,[],CHEMBL1033601,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in CD-1 mouse lung after 1 day after 1st successive aerosol infection run,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,0,=,,log10cfu,,,4.27,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,4.27
48730,,,2675221,[],CHEMBL1033602,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in CD-1 mouse lung after 1 day after 2nd successive aerosol infection run,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,0,=,,log10cfu,,,4.4,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,4.4
48731,,,2675222,[],CHEMBL1033603,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in CD-1 mouse lung,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,0,=,,log10cfu,,,7.87,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,7.87
48732,,,2675223,[],CHEMBL1033604,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in CD-1 mouse lung measured after 28 days of aerosol infection run,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,0,=,,log10cfu,,,8.61,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,8.61
48733,,,2675224,[],CHEMBL1033606,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in CD-1 mouse lung measured after 53 days after aerosol infection,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,0,=,,log10cfu,,,4.39,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,4.39
48734,,,2675225,[],CHEMBL1033605,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in CD-1 mouse lung measured after 56 days after aerosol infection,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,0,=,,log10cfu,,,3.48,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,3.48
48735,,,2675226,[],CHEMBL1033607,Antimicrobial activity against Mycobacterium tuberculosis H37Rv infected in CD-1 mouse lung at 75 mg/kg administered through gavage,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,0,=,,log10cfu,,,0.93,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,0.93
48736,,,2675227,[],CHEMBL1033610,AUC (0 to 24 hrs)/MIC in Mycobacterium tuberculosis H37Rv infected in CD-1 mouse,F,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,819275,=,1,0,=,,RatioAUC/MIC,,,54.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,RatioAUC/MIC,,,,54.8
48737,,,2675228,[],CHEMBL1033608,Half life in mouse,A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151451,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,819275,=,1,1,=,,T1/2,hr,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,1.0
48738,,,2680102,[],CHEMBL1060637,Bactericidal activity against Streptococcus pneumoniae ATCC 49619 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48739,,,2680103,[],CHEMBL1060638,Bactericidal activity against Streptococcus pneumoniae isolate SR-23958 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
48740,,,2680104,[],CHEMBL1060639,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48741,,,2680105,[],CHEMBL1060640,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48742,,,2680106,[],CHEMBL1060641,Bactericidal activity against Streptococcus pneumoniae ATCC 49619 assessed as mutant prevention concentration after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,0,=,,MPC,ug ml-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MPC,ug ml-1,UO_0000274,,0.5
48743,,,2680107,[],CHEMBL1060642,Bactericidal activity against Streptococcus pneumoniae isolate SR-23958 assessed as mutant prevention concentration after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,0,=,,MPC,ug ml-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MPC,ug ml-1,UO_0000274,,0.5
48744,,,2680108,[],CHEMBL1060643,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 assessed as mutant prevention concentration after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,0,=,,MPC,ug ml-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MPC,ug ml-1,UO_0000274,,1.0
48745,,,2680109,[],CHEMBL1060644,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 ParC Ser79Phe assessed as mutant prevention concentration after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,0,=,,MPC,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MPC,ug ml-1,UO_0000274,,8.0
48746,,,2680118,[],CHEMBL1060645,Ratio of mutant prevention concentration for Streptococcus pneumoniae ATCC 49619 to MIC for Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,2.0
48747,,,2680119,[],CHEMBL1060646,Ratio of mutant prevention concentration for Streptococcus pneumoniae isolate SR-23958 to MIC for Streptococcus pneumoniae isolate SR-23958,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,2.0
48748,,,2680120,[],CHEMBL1060647,Ratio of mutant prevention concentration for Streptococcus pneumoniae isolate SR-26134 to MIC for Streptococcus pneumoniae isolate SR-26134,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,2.0
48749,,,2680121,[],CHEMBL1061509,Ratio of mutant prevention concentration for Streptococcus pneumoniae isolate SR-26137 to MIC for Streptococcus pneumoniae isolate SR-26137,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,32.0
48750,,,2680126,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1063298,"AUC (0 to 24 hrs) in human at 400 mg, po administered once a day",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,1,=,,AUC,ng.hr.mL-1,,19780.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,19.78
48751,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2680127,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1063299,"Cmax in human at 400 mg, po administered once a day",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,823126,=,1,1,=,,Cmax,nM,,4060.38,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,1.63
48752,,,2680128,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '80.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '80.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1063300,"AUC (0 to 24 hrs) in human at 80 mg, po administered once a day",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,1,=,,AUC,ng.hr.mL-1,,3960.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,3.96
48753,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2680129,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '80.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '80.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1063301,"Cmax in human at 80 mg, po administered once a day",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,823126,=,1,1,=,,Cmax,nM,,822.04,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,0.33
48754,,,2680130,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '200.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1063302,"AUC (0 to 24 hrs) in human at 200 mg, po administered twice a day",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,1,=,,AUC,ng.hr.mL-1,,26810.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,26.81
48755,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2680131,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '200.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1063303,"Cmax in human at 200 mg, po administered twice a day",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,823126,=,1,1,=,,Cmax,nM,,5978.48,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,2.4
48756,,,2680132,[],CHEMBL1063304,"Fraction unbound in human serum at 400 mg, po",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,1,=,,Fu,,,0.47,CHEMBL613426,Homo sapiens,Serum,9606.0,,,Fu,%,,,47.0
48757,,,2680134,[],CHEMBL1063306,Antibacterial activity against 80 mg q.d. moxifloxacin-pretreated Streptococcus pneumoniae isolate SR-26134 after 48 hrs of incubation by population analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48758,,,2680135,[],CHEMBL1063307,Antibacterial activity against 200 mg b.i.d. levofloxacin-pretreated Streptococcus pneumoniae isolate SR-26134 after 48 hrs of incubation by population analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48759,,,2680136,[],CHEMBL1063308,Antibacterial activity against 80 mg q.d. moxifloxacin-pretreated Streptococcus pneumoniae isolate SR-26137 after 48 hrs of incubation by population analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48760,,,2680137,[],CHEMBL1063309,Antibacterial activity against 200 mg b.i.d. levofloxacin-pretreated Streptococcus pneumoniae isolate SR-26137 after 48 hrs of incubation by population analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823126,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48761,,,2680144,[],CHEMBL1064113,"Ratio of AUC (0 to 24 hrs) in human at 400 mg, po administered once daily to MIC for Streptococcus pneumoniae ATCC 49619",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,158.24,CHEMBL612545,,Unchecked,,,,Ratio,,,,158.24
48762,,,2680145,[],CHEMBL1064116,"Ratio of AUC (0 to 24 hrs) in human at 400 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-26137",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,79.12,CHEMBL612545,,Unchecked,,,,Ratio,,,,79.12
48763,,,2680146,[],CHEMBL1064114,"Ratio of AUC (0 to 24 hrs) in human at 400 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-23958",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,158.24,CHEMBL612545,,Unchecked,,,,Ratio,,,,158.24
48764,,,2680147,[],CHEMBL1064115,"Ratio of AUC (0 to 24 hrs) in human at 400 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-26134",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,79.12,CHEMBL612545,,Unchecked,,,,Ratio,,,,79.12
48765,,,2680148,[],CHEMBL1064117,"Ratio of AUC (0 to 24 hrs) in human at 80 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-26134",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,15.82,CHEMBL612545,,Unchecked,,,,Ratio,,,,15.82
48766,,,2680149,[],CHEMBL1064118,"Ratio of AUC (0 to 24 hrs) in human at 80 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-26137",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,15.82,CHEMBL612545,,Unchecked,,,,Ratio,,,,15.82
48767,,,2680151,[],CHEMBL1064124,"Ratio of Cmax in human at 400 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-23958",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,13.05,CHEMBL612545,,Unchecked,,,,Ratio,,,,13.05
48768,,,2680155,[],CHEMBL1064123,"Ratio of Cmax in human at 400 mg, po administered once daily to MIC for Streptococcus pneumoniae ATCC 49619",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,13.05,CHEMBL612545,,Unchecked,,,,Ratio,,,,13.05
48769,,,2680156,[],CHEMBL1064125,"Ratio of Cmax in human at 400 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-26134",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,6.53,CHEMBL612545,,Unchecked,,,,Ratio,,,,6.53
48770,,,2680157,[],CHEMBL1064126,"Ratio of Cmax in human at 400 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-26137",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,6.53,CHEMBL612545,,Unchecked,,,,Ratio,,,,6.53
48771,,,2680158,[],CHEMBL1064127,"Ratio of Cmax in human at 80 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-26134",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,1.31,CHEMBL612545,,Unchecked,,,,Ratio,,,,1.31
48772,,,2680159,[],CHEMBL1064128,"Ratio of Cmax in human at 80 mg, po administered once daily to MIC for Streptococcus pneumoniae isolate SR-26137",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,1.31,CHEMBL612545,,Unchecked,,,,Ratio,,,,1.31
48773,,,2680164,[],CHEMBL1064133,"Ratio of AUC (0 to 24 hrs) in human at 400 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae ATCC 49619",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,39.56,CHEMBL612545,,Unchecked,,,,Ratio,,,,39.56
48774,,,2680165,[],CHEMBL1064134,"Ratio of AUC (0 to 24 hrs) in human at 400 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-23958",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,39.56,CHEMBL612545,,Unchecked,,,,Ratio,,,,39.56
48775,,,2680166,[],CHEMBL1064135,"Ratio of AUC (0 to 24 hrs) in human at 400 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26134",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,19.78,CHEMBL612545,,Unchecked,,,,Ratio,,,,19.78
48776,,,2680167,[],CHEMBL1064136,"Ratio of AUC (0 to 24 hrs) in human at 400 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26137",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,2.47,CHEMBL612545,,Unchecked,,,,Ratio,,,,2.47
48777,,,2680168,[],CHEMBL1064137,"Ratio of AUC (0 to 24 hrs) in human at 80 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26134",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,3.96,CHEMBL612545,,Unchecked,,,,Ratio,,,,3.96
48778,,,2680169,[],CHEMBL1064138,"Ratio of AUC (0 to 24 hrs) in human at 80 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26137",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,0.49,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.49
48779,,,2680174,[],CHEMBL1064143,"Ratio of Cmax in human at 400 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae ATCC 49619",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,3.26,CHEMBL612545,,Unchecked,,,,Ratio,,,,3.26
48780,,,2680175,[],CHEMBL1064144,"Ratio of Cmax in human at 400 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-23958",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,3.26,CHEMBL612545,,Unchecked,,,,Ratio,,,,3.26
48781,,,2680176,[],CHEMBL1057136,"Ratio of Cmax in human at 400 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26134",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,1.63,CHEMBL612545,,Unchecked,,,,Ratio,,,,1.63
48782,,,2680177,[],CHEMBL1057137,"Ratio of Cmax in human at 400 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26137",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,0.2,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.2
48783,,,2680178,[],CHEMBL1057138,"Ratio of Cmax in human at 80 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26134",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,0.33,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.33
48784,,,2680179,[],CHEMBL1057139,"Ratio of Cmax in human at 80 mg, po administered once daily to mutant prevention concentration for Streptococcus pneumoniae isolate SR-26137",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,=,1,0,=,,Ratio,,,0.04,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.04
48785,,,2680184,[],CHEMBL1057144,"TMSW in Streptococcus pneumoniae ATCC 49619 infected human at 400 mg, po administered once daily after 24 hrs",U,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,TMSW,%,,21.81,CHEMBL612545,,Unchecked,,,,TMSW,%,UO_0000187,,21.81
48786,,,2680185,[],CHEMBL1057145,"TMSW in Streptococcus pneumoniae isolate SR-23958 infected human at 400 mg, po administered once daily after 24 hrs",U,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,TMSW,%,,21.81,CHEMBL612545,,Unchecked,,,,TMSW,%,UO_0000187,,21.81
48787,,,2680186,[],CHEMBL1057146,"TMSW in Streptococcus pneumoniae isolate SR-26134 infected human at 400 mg, po administered once daily after 24 hrs",U,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,TMSW,%,,69.58,CHEMBL612545,,Unchecked,,,,TMSW,%,UO_0000187,,69.58
48788,,,2680187,[],CHEMBL1057147,"TMSW in Streptococcus pneumoniae isolate SR-26137 infected human at 400 mg, po administered once daily after 24 hrs",U,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,TMSW,%,,99.51,CHEMBL612545,,Unchecked,,,,TMSW,%,UO_0000187,,99.51
48789,,,2680188,[],CHEMBL1057148,"TMSW in Streptococcus pneumoniae isolate SR-26134 infected human at 80 mg, po administered once daily after 24 hrs",U,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,TMSW,%,,16.88,CHEMBL612545,,Unchecked,,,,TMSW,%,UO_0000187,,16.88
48790,,,2680189,[],CHEMBL1057149,"TMSW in Streptococcus pneumoniae isolate SR-26137 infected human at 80 mg, po administered once daily after 24 hrs",U,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,TMSW,%,,16.88,CHEMBL612545,,Unchecked,,,,TMSW,%,UO_0000187,,16.88
48791,,,2680194,[],CHEMBL1057153,"Time above the mutant prevention concentration in Streptococcus pneumoniae ATCC 49619 infected human at 400 mg, po administered once daily after 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,Activity,%,,77.78,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,77.78
48792,,,2680195,[],CHEMBL1057154,"Time above the mutant prevention concentration in Streptococcus pneumoniae isolate SR-23958 infected human at 400 mg, po administered once daily after 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,Activity,%,,77.78,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,77.78
48793,,,2680196,[],CHEMBL1057155,"Time above the mutant prevention concentration in Streptococcus pneumoniae isolate SR-26134 infected human at 400 mg, po administered once daily after 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,Activity,%,,30.14,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,30.14
48794,,,2680197,[],CHEMBL1057156,"Time above the mutant prevention concentration in Streptococcus pneumoniae isolate SR-26137 infected human at 400 mg, po administered once daily after 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,Activity,%,,0.0,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.0
48795,,,2680198,[],CHEMBL1057157,"Time above the mutant prevention concentration in Streptococcus pneumoniae isolate SR-26134 infected human at 80 mg, po administered once daily after 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,Activity,%,,0.0,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.0
48796,,,2680199,[],CHEMBL1057158,"Time above the mutant prevention concentration in Streptococcus pneumoniae isolate SR-26137 infected human at 80 mg, po administered once daily after 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,823126,=,1,0,=,,Activity,%,,0.0,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.0
48797,,Active,2680204,[],CHEMBL1057163,Bactericidal activity against Streptococcus pneumoniae ATCC 49619 assessed as reduction in number of viable cells under condition simulating oral administration of 400 mg once daily,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
48798,,Active,2680205,[],CHEMBL1057164,Bactericidal activity against Streptococcus pneumoniae isolate SR-23958 assessed as reduction in number of viable cells under condition simulating oral administration of 400 mg once daily,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
48799,,Active,2680206,[],CHEMBL1057165,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 assessed as reduction in number of viable cells under condition simulating oral administration of 400 mg once daily,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
48800,,Active,2680207,[],CHEMBL1057166,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 assessed as reduction in number of viable cells under condition simulating oral administration of 400 mg once daily,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
48801,,Active,2680208,[],CHEMBL1057167,Bactericidal activity against Streptococcus pneumoniae ATCC 49619 assessed as prevention of bacterial regrowth under condition simulating oral administration of 400 mg once daily after 72 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
48802,,Active,2680209,[],CHEMBL1057168,Bactericidal activity against Streptococcus pneumoniae isolate SR-23958 assessed as prevention of bacterial regrowth under condition simulating oral administration of 400 mg once daily after 72 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
48803,,Active,2680210,[],CHEMBL1057960,Bactericidal activity against Streptococcus pneumoniae isolate SR-26134 assessed as prevention of bacterial regrowth under condition simulating oral administration of 400 mg once daily after 72 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
48804,,Active,2680211,[],CHEMBL1057961,Bactericidal activity against Streptococcus pneumoniae isolate SR-26137 assessed as prevention of bacterial regrowth under condition simulating oral administration of 400 mg once daily after 72 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152453,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,823126,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
48805,,,2684955,[],CHEMBL1056341,Antimicrobial activity against Acinetobacter baumannii BM4454 isolated from patient with urinary tract infection by E test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823044,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
48806,,,2684967,[],CHEMBL1056342,Antimicrobial activity against Acinetobacter baumannii BM4652 expressing adeABC adeIJK double mutant isolated from patient with urinary tract infection by E test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823044,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
48807,,,2684979,[],CHEMBL1056343,Antimicrobial activity against Acinetobacter baumannii BM4579 expressing deltaadeIJK genes isolated from patient with urinary tract infection by E test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823044,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
48808,,,2684991,[],CHEMBL1056344,Antimicrobial activity against Acinetobacter baumannii BM4651 expressing deltaadeIJK genes isolated from patient with urinary tract infection by E test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823044,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,3.0
48809,,,2685003,[],CHEMBL1063234,Antimicrobial activity against Acinetobacter baumannii BM4652 expressing adeIJK genes with pAT807 isolated from patient with urinary tract infection by E test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823044,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
48810,,,2685015,[],CHEMBL1063235,Antimicrobial activity against Acinetobacter baumannii BM4579 expressing adeIJK genes with pAT807 isolated from patient with urinary tract infection by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152472,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823044,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
48811,,,2711140,[],CHEMBL1053372,"Antibacterial activity against Escherichia coli 1596 containing gyrA L83 and parC I80, G84 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1608 containing gyrA mutant",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,826416,=,1,0,=,,Ratio,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,1.0
48812,,,2711146,[],CHEMBL1053371,"Antibacterial activity against Escherichia coli 1608 containing gyrA L83, L87 mutants assessed as increase in MIC by Etest relative to MIC for wild type Escherichia coli 1609",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,826416,=,1,0,=,,Ratio,,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,5.0
48813,,,2711157,[],CHEMBL1053373,Antibacterial activity against Escherichia coli 1596 containing parC K84 mutant assessed as decrease in MIC by Etest relative to MIC for Escherichia coli 1608 containing gyrA mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826416,=,1,1,=,,MIC,ug.mL-1,,0.028,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.028
48814,,,2711160,[],CHEMBL1053374,"Antibacterial activity against Escherichia coli SKM9 containing gyrA L83, Y87 and parC L80 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1596 containing gyrA L83 and parC I80 mutants",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,826416,=,1,0,=,,Ratio,,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,9.0
48815,,,2711165,[],CHEMBL1053375,"Antibacterial activity against Escherichia coli SKM18 containing gyrA L83, Y87 and parC L80, G84 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli SKM9 containing gyrA L83, Y87 and parC L80 mutants",F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,826416,=,1,0,=,,Ratio,,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,10.0
48816,,,2711166,[],CHEMBL1053376,Antibacterial activity against Escherichia coli 1608 containing gyrA L83 mutant assessed as increase in MIC by Etest relative to MIC for wild type Escherichia coli 1609,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,826416,=,1,0,=,,Ratio,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,1.0
48817,,,2727636,[],CHEMBL1055082,Inhibition of Mycobacterium leprae wild type DNA gyrase A2B2 assessed as DNA supercoiling inhibition,B,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830014,=,1,1,=,,IC50,ug.mL-1,,6.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,6.0
48818,,,2727637,[],CHEMBL1055083,Inhibition of Mycobacterium leprae DNA gyrase subunit A G89C mutant assessed as DNA supercoiling inhibition,B,Q57532,G89C,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830014,=,1,1,=,,IC50,ug.mL-1,,30.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,30.0
48819,,,2727638,[],CHEMBL1055084,Inhibition of Mycobacterium leprae DNA gyrase subunit A A91V mutant assessed as DNA supercoiling inhibition,B,Q57532,A91V,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830014,=,1,1,=,,IC50,ug.mL-1,,25.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,25.0
48820,,,2727639,[],CHEMBL1055085,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit B D205N mutant assessed as DNA supercoiling inhibition,B,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830014,=,1,1,=,,IC50,ug.mL-1,,6.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,6.0
48821,,,2727640,[],CHEMBL1055086,Inhibition of Mycobacterium leprae wild type DNA gyrase A2B2 assessed as formation of DNA cleavable complex,B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830014,=,1,0,=,,CC25,ug ml-1,,0.8,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,0.8
48822,,Not Active,2727641,[],CHEMBL1055127,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit A G89A mutant assessed as formation of DNA cleavable complex,B,Q57532,G89A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,830014,,1,0,,,CC25,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,,,,
48823,,,2727642,[],CHEMBL1055128,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit A A91V mutant assessed as formation of DNA cleavable complex,B,Q57532,A91V,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830014,=,1,0,=,,CC25,ug ml-1,,12.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,12.0
48824,,,2727643,[],CHEMBL1055129,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit B D205N mutant assessed as formation of DNA cleavable complex,B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,830014,=,1,0,=,,CC25,ug ml-1,,0.7,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,0.7
48825,,,2727644,[],CHEMBL1055130,"Selectivity index, ratio of IC50 for Mycobacterium leprae DNA gyrase subunit A G89C mutant to IC50 for Mycobacterium leprae wild type DNA gyrase A2B2",B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,830014,=,1,0,=,,FC,,,3.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,FC,,,,3.0
48826,,,2727645,[],CHEMBL1055131,"Selectivity index, ratio of IC50 for Mycobacterium leprae DNA gyrase subunit A A91V mutant to IC50 for Mycobacterium leprae wild type DNA gyrase A2B2",B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,830014,=,1,0,=,,FC,,,5.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,FC,,,,5.0
48827,,,2727691,[],CHEMBL1055132,"Selectivity index, ratio of CC25 for Mycobacterium leprae DNA gyrase subunit A A91V mutant to CC25 for Mycobacterium leprae wild type DNA gyrase A2B2 by DNA cleavage assay",B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1153562,Antimicrob Agents Chemother,2008.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,830014,=,1,0,=,,FC,,,12.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,FC,,,,12.0
48828,,,2914878,[],CHEMBL1050054,Inhibition of human HeLa cell proliferation assessed as bromodeoxyuridine incorporation during DNA synthesis after 48 hrs by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,847441,=,1,1,=,,IC50,nM,,320000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,uM,UO_0000065,,320.0
48829,,,2914879,[],CHEMBL1050055,Inhibition of human MG63 cell proliferation assessed as bromodeoxyuridine incorporation during DNA synthesis after 48 hrs by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,847441,=,1,1,=,,IC50,nM,,230000.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,uM,UO_0000065,,230.0
48830,,,2930123,[],CHEMBL1061238,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv replicating form by alamar blue assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155230,J Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,853037,=,1,1,=,,MIC90,nM,,460.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.46
48831,,,2930607,[],CHEMBL1061239,Antimycobacterial activity against non replicating persistent form of Mycobacterium tuberculosis H37Rv after 10 days by low oxygen recovery assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155230,J Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,853037,>,1,1,>,,MIC90,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,128.0
48832,,,2946604,[],CHEMBL1041438,Antimalarial activity against Plasmodium falciparum 3D7,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,849397,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,10.0
48833,,,2946607,[],CHEMBL1041439,Antimalarial activity against Plasmodium falciparum NF54,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,849397,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,10.0
48834,,,2978287,[],CHEMBL1043586,Fraction escaping gut-wall elimination in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,0,=,,Fg,,,1.04,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fg,,,,1.04
48835,,,2978390,[],CHEMBL1043588,Volume of distribution at steady state in human,A,,,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,1,=,,Vdss,L.kg-1,,1.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,1.4
48836,,,2978482,[],CHEMBL1043582,Hepatic clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,1,=,,CL,mL.min-1.kg-1,,1.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,1.9
48837,,,2978548,[],CHEMBL1043581,Total clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,1,=,,CL,mL.min-1.kg-1,,2.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,2.4
48838,,,2992121,[],CHEMBL1043583,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,1,=,,CL_renal,mL.min-1.kg-1,,0.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,0.5
48839,,,2993290,[],CHEMBL1043580,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,1,=,,Fu,,,0.6,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Fu,,,,0.6
48840,,,2994739,[],CHEMBL1043584,Oral bioavailability in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,0,=,,F_fraction,,,0.86,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F_fraction,,,,0.86
48841,,,2994853,[],CHEMBL1043585,Fraction absorbed in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,0,=,,Fa,,,0.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fa,,,,0.9
48842,,,2994911,[],CHEMBL1043587,Fraction escaping hepatic elimination in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,863733,=,1,0,=,,Fh,,,0.92,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fh,,,,0.92
48843,,,3070511,[],CHEMBL1066048,Antibacterial activity against Staphylococcus aureus FDA 209-P after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.013
48844,,,3070524,[],CHEMBL1066049,Antibacterial activity against Staphylococcus epidermidis 56500 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.1
48845,,,3070537,[],CHEMBL1066050,Antibacterial activity against Streptococcus pneumoniae J-24 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.025
48846,,,3070550,[],CHEMBL1066051,Antibacterial activity against Streptococcus pyogenes G-36 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.2
48847,,,3070563,[],CHEMBL1066052,Antibacterial activity against Streptococcus mitis IID685 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.1
48848,,,3070576,[],CHEMBL1066053,Antibacterial activity against Enterococcus faecalis ATCC 19433 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.2
48849,,,3071601,[],CHEMBL1066054,Antibacterial activity against Escherichia coli NIHJ after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
48850,,,3071614,[],CHEMBL1066055,Antibacterial activity against Klebsiella pneumoniae type 2 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
48851,,,3071627,[],CHEMBL1066056,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
48852,,,3071641,[],CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
48853,,,3071648,[],CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC80,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC80,ug ml-1,UO_0000274,,32.0
48854,,,3071655,[],CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48855,,,3071683,[],CHEMBL1066703,Inhibition of Staphylococcus aureus wild type DNA topoisomerase 4,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,IC50,ug.mL-1,,1.36,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,1.36
48856,,,3071689,[],CHEMBL1066706,Inhibition of Staphylococcus aureus wild type DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,IC50,ug.mL-1,,4.38,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,ug ml-1,UO_0000274,,4.38
48857,,,3071696,[],CHEMBL1066705,Selectivity ratio of IC50 for Staphylococcus aureus DNA topoisomerase 4 Ser80Phe mutant to IC50 for Staphylococcus aureus wild type DNA topoisomerase 4,B,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,875100,=,1,0,=,,Ratio IC50,,,17.79,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,17.79
48858,,,3071704,[],CHEMBL1066704,Inhibition of Staphylococcus aureus DNA topoisomerase 4 Ser80Phe mutant,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,IC50,ug.mL-1,,24.2,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,24.2
48859,,,3071711,[],CHEMBL1066708,Selectivity ratio of IC50 for Staphylococcus aureus DNA gyrase Ser84Leu mutant to IC50 for Staphylococcus aureus wild type DNA gyrase,B,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,875100,>,1,0,>,,Ratio IC50,,,117.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,117.0
48860,,,3071714,[],CHEMBL1066707,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant,B,P20831,S84L,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,>,1,1,>,,IC50,ug.mL-1,,512.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,IC50,ug ml-1,UO_0000274,,512.0
48861,,,3071717,[],CHEMBL1066065,"Antibacterial activity against ciprofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,2.0
48862,,,3071724,[],CHEMBL1066065,"Antibacterial activity against ciprofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48863,,,3071731,[],CHEMBL1066700,Antibacterial activity against penicillin-intermediate resistant Streptococcus pneumoniae after 18 hrs by twofold microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48864,,,3071738,[],CHEMBL1066700,Antibacterial activity against penicillin-intermediate resistant Streptococcus pneumoniae after 18 hrs by twofold microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48865,,,3071745,[],CHEMBL1066701,Antibacterial activity against vancomycin-resistant Enterococcus faecalis after 18 hrs by twofold microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,16.0
48866,,,3071752,[],CHEMBL1066701,Antibacterial activity against vancomycin-resistant Enterococcus faecalis after 18 hrs by twofold microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48867,,,3071759,[],CHEMBL1066702,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 18 hrs by twofold microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,4.0
48868,,,3071766,[],CHEMBL1066702,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 18 hrs by twofold microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875100,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,32.0
48869,,,3096797,[],CHEMBL1074169,Antitubercular activity against Mycobacterium tuberculosis H37Rv by microplate Alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1159089,Bioorg Med Chem Lett,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,883148,=,1,1,=,,MIC,nM,,290.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.29
48870,,,3097934,[],CHEMBL1074170,Antitubercular activity against Mycobacterium tuberculosis H37Rv by low-oxygen-recovery assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1159089,Bioorg Med Chem Lett,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,883148,=,1,1,=,,MIC,nM,,31100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,31.1
48871,,,3310530,[],CHEMBL1119560,Antibacterial activity against Escherichia coli ATCC 25922 by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,<,1,1,<,,MIC,ug.mL-1,,0.08,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.08
48872,,,3310531,[],CHEMBL1119561,Antibacterial activity against Staphylococcus aureus ATCC 25923 by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,<,1,1,<,,MIC,ug.mL-1,,0.08,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.08
48873,,,3310532,[],CHEMBL1119559,Antibacterial activity against methicillin and ciprofloxacin-resistant Staphylococcus aureus 25A by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
48874,,,3310533,[],CHEMBL1119558,Antibacterial activity against Staphylococcus aureus SA-K1902 bearing norA- deficient mutation by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.08
48875,,,3310534,[],CHEMBL1119562,Antibacterial activity against Staphylococcus aureus SA-K1904 bearing norA++ efficient mutation by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.08
48876,,,3310535,[],CHEMBL1119700,Antibacterial activity against wild-type norA expressing Staphylococcus aureus SA-1199 by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.08
48877,,,3310536,[],CHEMBL1119701,Antibacterial activity against Staphylococcus aureus SA-1199B norA++ and A116E GrlA mutation by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
48878,,,3310579,[],CHEMBL1119702,Antibacterial activity against Staphylococcus aureus K1035 bearing wild-type GyrA and S80F mutant GrlA by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,0.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.31
48879,,,3310580,[],CHEMBL1119703,Antibacterial activity against Staphylococcus aureus K1134 bearing wild-type GyrA and S80Y mutant GrlA by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,0.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.31
48880,,,3310581,[],CHEMBL1119704,Antibacterial activity against Staphylococcus aureus K1305 bearing wild-type GyrA and E84K mutant GrlA by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,0.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.31
48881,,,3310582,[],CHEMBL1119705,Antibacterial activity against Staphylococcus aureus K1628 bearing S84L mutant GyrA and S80F mutant GrlA by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
48882,,,3310583,[],CHEMBL1119706,Antibacterial activity against Staphylococcus aureus K1640 bearing S84L mutant GyrA and S80Y mutant GrlA by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155486,J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,915569,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.5
48883,,,3364306,[],CHEMBL1177383,Antibacterial activity against Staphylococcus aureus ATCC 12600 after 48 hrs by microtiter plate assay,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1177733,J Nat Prod,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.12,0,http://www.openphacts.org/units/Nanomolar,926056,=,1,1,=,,IC50,nM,,7500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,uM,UO_0000065,,7.5
48884,,,3371111,[],CHEMBL1211291,Antimycobacterial activity against Mycobacterium phlei CMCC 93201 after 72 hrs by serial double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1208676,Eur J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,927737,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,,MIC,ug ml-1,UO_0000274,,0.2
48885,,,3371127,[],CHEMBL1211292,Antimycobacterial activity against Mycobacterium smegmatis CMCC 93202 after 72 hrs by serial double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1208676,Eur J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,927737,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.1
48886,,,3371143,[],CHEMBL1211295,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1208676,Eur J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,927737,=,1,0,=,,CC50,,,160.8,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,CC50,,,,160.8
48887,,,3371150,[],CHEMBL1211293,Antimycobacterial activity against Mycobacterium tuberculosis 09710 after 72 hrs by serial double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1208676,Eur J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,927737,<,1,1,<,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
48888,,,3371158,[],CHEMBL1211294,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 72 hrs by serial double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1208676,Eur J Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,927737,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
48889,,,3383897,[],CHEMBL1220798,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes at 10 ug by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Millimeter,930662,=,1,1,=,,IZ,mm,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,0.0
48890,,,3383898,[],CHEMBL1220799,Antimicrobial activity against strong ciprofloxacin-resistant Streptococcus pyogenes at 10 ug by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Millimeter,930662,=,1,1,=,,IZ,mm,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,0.0
48891,,,3383899,[],CHEMBL1220800,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene at 10 ug by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Millimeter,930662,=,1,1,=,,IZ,mm,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,0.0
48892,,,3384905,[],CHEMBL1220526,"Distribution coefficient, log D of the compound",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,929570,=,1,1,=,,LogD,,,-0.28,CHEMBL2362975,,No relevant target,,,,logD,,,,-0.28
48893,,,3384911,[],CHEMBL1220654,Apparent permeability across apical to basolateral side in human Calu3 cells,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,929570,=,1,0,=,,Papp,10'-6 cm/s,,5.0,CHEMBL612558,,ADMET,,,,Papp,10'-6 cm/s,,,5.0
48894,,,3384917,[],CHEMBL1220655,Apparent permeability across basolateral to apical side in human Calu3 cells,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,929570,=,1,0,=,,Papp,10'-6 cm/s,,10.4,CHEMBL612558,,ADMET,,,,Papp,10'-6 cm/s,,,10.4
48895,,,3384923,[],CHEMBL1220656,Efflux ratio of apparent permeability across basolateral to apical side over apical to basolateral side in human Calu3 cells,A,,,BAO_0000193,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,929570,=,1,0,=,,Ratio,,,2.1,CHEMBL612558,,ADMET,,,,Ratio,,,,2.1
48896,,,3384929,[],CHEMBL1220657,Apparent permeability across apical to basolateral side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,929570,=,1,0,=,,Papp,10'-6 cm/s,,8.3,CHEMBL612558,,ADMET,,,,Papp,10'-6 cm/s,,,8.3
48897,,,3384935,[],CHEMBL1220658,Apparent permeability across basolateral to apical side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,,,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,929570,=,1,0,=,,Papp,10'-6 cm/s,,7.8,CHEMBL612558,,ADMET,,,,Papp,10'-6 cm/s,,,7.8
48898,,,3384941,[],CHEMBL1220659,Efflux ratio of apparent permeability across basolateral to apical side over apical to basolateral side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,,,BAO_0000193,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,929570,=,1,0,=,,Ratio,,,0.9,CHEMBL612558,,ADMET,,,,Ratio,,,,0.9
48899,,,3385305,[],CHEMBL1221038,Antibacterial activity against Stenotrophomonas maltophilia D457 containing chromosomally encoded Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.19
48900,,,3385306,[],CHEMBL1221039,Antibacterial activity against Stenotrophomonas maltophilia MBS108 containing both chromosomally and plasmid encoded Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930146,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.75
48901,,,3385307,[],CHEMBL1221040,Antibacterial activity against Stenotrophomonas maltophilia MBS109 containing chromosomally encoded Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930146,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.19
48902,,,3385308,[],CHEMBL1221041,Antibacterial activity against Stenotrophomonas maltophilia MBS82 deficient in Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930146,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.064
48903,,,3385309,[],CHEMBL1221042,Antibacterial activity against Stenotrophomonas maltophilia MBS101 containing plasmid encoded Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930146,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.75
48904,,,3385310,[],CHEMBL1221043,Antibacterial activity against Stenotrophomonas maltophilia MBS100 deficient in Smqnr gene by epsilon test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212754,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930146,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,mg/L,UO_0000274,,0.064
48905,,,3389539,[],CHEMBL1216830,Antibacterial activity against Streptococcus pneumoniae 1151 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,>,1,0,>,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
48906,,,3389542,[],CHEMBL1216829,Antibacterial activity against Streptococcus pneumoniae 1149 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,>,1,0,>,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
48907,,,3389545,[],CHEMBL1216828,Antibacterial activity against Streptococcus pneumoniae 1072 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,0,=,,Activity,ug ml-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,64.0
48908,,,3389548,[],CHEMBL1216827,Antibacterial activity against Streptococcus pneumoniae 1135 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
48909,,,3389551,[],CHEMBL1216826,Antibacterial activity against Streptococcus pneumoniae 1065 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48910,,,3389554,[],CHEMBL1216825,Antibacterial activity against Streptococcus pneumoniae 1058 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48911,,,3389557,[],CHEMBL1216824,Antibacterial activity against Streptococcus pneumoniae 3321 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48912,,,3389560,[],CHEMBL1216823,Antibacterial activity against Streptococcus pneumoniae 1151 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
48913,,,3389563,[],CHEMBL1216822,Antibacterial activity against Streptococcus pneumoniae 1149 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
48914,,,3389566,[],CHEMBL1216821,Antibacterial activity against Streptococcus pneumoniae 1072 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
48915,,,3389569,[],CHEMBL1216820,Ratio of 90% mutant prevention concentration to MIC90 in Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,930786,=,1,0,=,,Ratio,,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,4.0
48916,,,3389572,[],CHEMBL1216819,Ratio of 50% mutant prevention concentration to MIC50 in Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,930786,=,1,0,=,,Ratio,,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,2.0
48917,,,3389575,[],CHEMBL1216818,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as 90% mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,16.0
48918,,,3389578,[],CHEMBL1216817,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as 50% mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,0,=,,Activity,ug ml-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,1.0
48919,,,3389581,[],CHEMBL1216816,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
48920,,,3389584,[],CHEMBL1216816,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
48921,,,3389588,[],CHEMBL1216831,Antibacterial activity against Streptococcus pneumoniae 3321 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,>,1,0,>,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
48922,,,3389591,[],CHEMBL1216832,Antibacterial activity against Streptococcus pneumoniae 1058 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,>,1,0,>,,Activity,ug ml-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,4.0
48923,,,3389594,[],CHEMBL1216833,Antibacterial activity against Streptococcus pneumoniae 1065 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,>,1,0,>,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
48924,,,3389597,[],CHEMBL1216834,Antibacterial activity against Streptococcus pneumoniae 1135 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930786,=,1,0,=,,Activity,ug ml-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,32.0
48925,,,3397710,[],CHEMBL1220793,Antimicrobial activity against strong ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930662,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
48926,,,3397717,[],CHEMBL1220794,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.5
48927,,,3397724,[],CHEMBL1220794,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930662,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48928,,,3397731,[],CHEMBL1220795,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930662,<=,1,1,<=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48929,,,3397738,[],CHEMBL1220795,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930662,<=,1,1,<=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48930,,,3402045,[],CHEMBL1219409,Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.015
48931,,,3402046,[],CHEMBL1219410,Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
48932,,,3402047,[],CHEMBL1219408,Antimicrobial activity against quinolone and penicillin-resistant Staphylococcus aureus SAR72 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.0
48933,,,3402048,[],CHEMBL1219412,Antimicrobial activity against quinolone and penicillin-resistant Staphylococcus aureus SAR4790 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
48934,,,3402049,[],CHEMBL1219411,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.07
48935,,,3402050,[],CHEMBL1219413,Antimicrobial activity against quinolone and penicillin-resistant Staphylococcus epidermidis SER after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,50.0
48936,,,3402051,[],CHEMBL1219414,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.15
48937,,,3402052,[],CHEMBL1219415,Antimicrobial activity against quinolone and penicillin-resistant Acinetobacter baumannii after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,50.0
48938,,,3402053,[],CHEMBL1219416,Antimicrobial activity against Escherichia coli ATCC 8739 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
48939,,,3402054,[],CHEMBL1219417,Antimicrobial activity against quinolone and penicillin-resistant Escherichia coli after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
48940,,,3402055,[],CHEMBL1219418,Antimicrobial activity against Haemophilus influenzae ATCC 19418 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.03
48941,,,3402056,[],CHEMBL1219419,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.7
48942,,,3402057,[],CHEMBL1219509,Antimicrobial activity against quinolone and penicillin-resistant Pseudomonas aeruginosa after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,100.0
48943,,,3402085,[],CHEMBL1219510,Inhibition of Escherichia coli DNA gyrase-mediated supercoiling of pBR322 using bromothymol blue by electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,IC50,ug.mL-1,,0.85,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.85
48944,,,3402086,[],CHEMBL1219511,Inhibition of Escherichia coli DNA topoisomerase-4-mediated decatenation of pBR322 by electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933298,=,1,1,=,,IC50,ug.mL-1,,5.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,5.0
48945,,,3450682,[],CHEMBL1245270,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring erm(B) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48946,,,3450698,[],CHEMBL1245270,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring erm(B) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48947,,,3450707,[],CHEMBL1245271,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48948,,,3450716,[],CHEMBL1245271,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48949,,,3450725,[],CHEMBL1245272,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring erm(B) and mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48950,,,3450734,[],CHEMBL1245272,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring erm(B) and mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48951,,,3450744,[],CHEMBL1245273,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring mutation in L4 ribosomal protein after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48952,,,3450753,[],CHEMBL1245273,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae harboring mutation in L4 ribosomal protein after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48953,,,3450761,[],CHEMBL1245258,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
48954,,,3450770,[],CHEMBL1245258,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
48955,,,3450779,[],CHEMBL1245259,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48956,,,3450788,[],CHEMBL1245259,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48957,,,3450797,[],CHEMBL1245260,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48958,,,3451583,[],CHEMBL1245260,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48959,,,3451592,[],CHEMBL1245261,Antibacterial activity against macrolide-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48960,,,3451601,[],CHEMBL1245261,Antibacterial activity against macrolide-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
48961,,,3451610,[],CHEMBL1245262,Antibacterial activity against Streptococcus pneumoniae harboring erm(B) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48962,,,3451619,[],CHEMBL1245262,Antibacterial activity against Streptococcus pneumoniae harboring erm(B) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48963,,,3451628,[],CHEMBL1245263,Antibacterial activity against Streptococcus pneumoniae harboring mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48964,,,3451637,[],CHEMBL1245263,Antibacterial activity against Streptococcus pneumoniae harboring mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48965,,,3451646,[],CHEMBL1245264,Antibacterial activity against Streptococcus pneumoniae harboring erm(A) gene after overnight incubation by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48966,,,3451655,[],CHEMBL1245265,Antibacterial activity against Streptococcus pneumoniae harboring erm(B) and mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48967,,,3451664,[],CHEMBL1245265,Antibacterial activity against Streptococcus pneumoniae harboring erm(B) and mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48968,,,3451673,[],CHEMBL1245266,Antibacterial activity against Streptococcus pneumoniae harboring mutation in L4 ribosomal protein after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48969,,,3451682,[],CHEMBL1245266,Antibacterial activity against Streptococcus pneumoniae harboring mutation in L4 ribosomal protein after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48970,,,3451691,[],CHEMBL1245267,Antibacterial activity against Streptococcus pneumoniae harboring mutation in 23S rRNA after overnight incubation by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
48971,,,3451700,[],CHEMBL1245268,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48972,,,3451709,[],CHEMBL1245268,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
48973,,,3451718,[],CHEMBL1245269,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,4.0
48974,,,3451727,[],CHEMBL1245269,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
48975,,,3451759,[],CHEMBL1245274,Antibacterial activity against macrolide-susceptible Streptococcus pyogenes after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48976,,,3451760,[],CHEMBL1245275,Antibacterial activity against Streptococcus pyogenes harboring erm(B) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48977,,,3451761,[],CHEMBL1245276,Antibacterial activity against Streptococcus pyogenes harboring mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48978,,,3451762,[],CHEMBL1245277,Antibacterial activity against Streptococcus pyogenes harboring erm(A) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48979,,,3451763,[],CHEMBL1245278,Antibacterial activity against Streptococcus pyogenes harboring mutation in L4 ribosomal protein after overnight incubation by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
48980,,,3451798,[],CHEMBL1245274,Antibacterial activity against macrolide-susceptible Streptococcus pyogenes after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48981,,,3451799,[],CHEMBL1245275,Antibacterial activity against Streptococcus pyogenes harboring erm(B) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48982,,,3451800,[],CHEMBL1245276,Antibacterial activity against Streptococcus pyogenes harboring mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48983,,,3451801,[],CHEMBL1245277,Antibacterial activity against Streptococcus pyogenes harboring erm(A) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48984,,,3451831,[],CHEMBL1245279,Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring erm(B) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48985,,,3451832,[],CHEMBL1245280,Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48986,,,3451833,[],CHEMBL1245281,Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring erm(A) gene after overnight incubation by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
48987,,,3451858,[],CHEMBL1245279,Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring erm(B) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48988,,,3451859,[],CHEMBL1245280,Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring mef(A) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48989,,,3451860,[],CHEMBL1245281,Antibacterial activity against macrolide-resistant Streptococcus pyogenes harboring erm(A) gene after overnight incubation by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240350,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953069,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
48990,,,3453993,[],CHEMBL1247538,Antibacterial activity against Haemophilus influenzae by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.015
48991,,,3454002,[],CHEMBL1247539,Antibacterial activity against ciprofloxacin resistant Neisseria gonorrhoeae isolates by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,2.0
48992,,,3454006,[],CHEMBL1247540,Antibacterial activity against levofloxacin resistant Neisseria gonorrhoeae isolates by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,1.0
48993,,,3454010,[],CHEMBL1247541,Antibacterial activity against moxifloxacin resistant Neisseria gonorrhoeae isolates by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,ug ml-1,UO_0000274,,0.5
48994,,,3454014,[],CHEMBL1247096,Antibacterial activity against methicillin susceptible Staphylococcus aureus by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.06
48995,,,3454023,[],CHEMBL1247097,Antibacterial activity against ciprofloxacin susceptible and methicillin resistant Staphylococcus aureus by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.06
48996,,,3454032,[],CHEMBL1247098,Antibacterial activity against ciprofloxacin and methicillin resistant Staphylococcus aureus by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
48997,,,3454041,[],CHEMBL1247099,Antibacterial activity against methicillin resistant coagulase negative Staphylococcus by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.12
48998,,,3454050,[],CHEMBL1247520,Antibacterial activity against methicillin resistant coagulase negative Staphylococcus epidermidis by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.12
48999,,,3454059,[],CHEMBL1247521,Antibacterial activity against Enterococcus faecalis by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1240400,Antimicrob Agents Chemother,2010.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953855,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,0.5
